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 “You never know how strong you are… 
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ABSTRACT 
 
Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and a 
frequent cause of hospitalization. Moreover, it represents one of the most frequent 
complication following cardiac surgery with an incidence of around 30% and an 
important predictor of patient morbidity. The exact pathophysiological mechanisms 
responsible for the onset and perpetuation of AF are not completely understood. 
However, clinical and experimental insights on the factors causing AF have suggested 
that atrial fibrillation is a multi-factorial phenomenon. Atrial fibrillation is characterized 
by a highly complex and irregular electrical activation of the atrial tissue, which is the 
manifestation of diverse abnormalities (electrical, structural, metabolic, neurohormonal, 
and/or molecular alterations) in diverse pathological conditions. In particular, it has 
been shown that fibrosis, a phenomenon in which extracellular matrix (ECM) 
components, mainly fibrillar collagen, accumulate between cardiomyocytes, leads to the 
inhomogeneous atrial electrical conduction typical of fibrillation. Recent studies have 
suggested that the deregulation of gene expression may act as a molecular mechanism 
of arrhythmogenesis. In particular, miRNAs, a new class of non-coding RNAs have 
rapidly emerged as one of the key players in the gene expression regulatory network, so 
variations in their expression levels may constitute a pathway for the arrhythmia-
induced atrial remodeling.  
The present study aims to investigate the structural and molecular features of atrial 
tissue, with particular attention to fibrosis, which may be involved in the formation of a 
pro-arrhythmic substrate. By using both histological and advanced microscopy 
techniques, intramural fibrotic content and 3D collagen network properties were 
determined in atrial samples, collected during cardiac surgery in patients who 
developed or not AF. The quantitative analysis indicated a general decrease of collagen 
content from the outer (the epicardium) to the inner (the endocardium) myocardial wall, 
in the overall patient population. However, AF patients presented higher fibrotic values 
compared to sinus rhythm (SR) patients in the deeper myocardial layers, thus 
supporting the hypothesis that an accumulation of fibrotic tissue within the myocardial 
wall may represent an important structural contributor in the pathophysiology of AF. In 
addition to a quantitative assessment, collagen properties such as fibers orientation 
(degree and anisotropy) and scale dimension, were determined by non-linear optical 
microscopy techniques. The analysis revealed that in SR patients collagen network 
showed a fine architecture characterized by thin fibrils with changing angles and 
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directions compared to AF, where fibers tended to pack-up in larger bundles of defined 
directions. A quantitative analysis of the 3D collagen network features, throughout the 
atrial wall, revealed that fibers orientation and scale dimension changed along tissue 
depth in both SR and AF patients, with larger values of orientation and fiber changes in 
AF tissues. These results highlight the spatial rearrangement and thickening of the 3D 
collagen network in AF patients, suggesting its possible role in the maintenance of the 
arrhythmia.  
Numerous evidence indicated that also an altered regulation of gene expression may 
play an important role in the mechanisms of atrial remodeling which underlie AF. In 
this perspective, the expression pattern of some miRNAs known to target different 
genes involved in diverse mechanisms that underlie AF was evaluated. A panel of 
miRNAs (miR-1, miR-133a/b, miR-30c, miR-29a/b, miR-208a/b, miR-328, miR-499, 
miR-590 and miR-21), principally involved in the formation of a pro-arrhythmic 
substrate, was selected after an accurate review of the literature and analyzed by RT-
qPCR, in AF patients versus SR individuals. To accurately determine the levels of 
analyzed miRNAs, their expression data are usually normalized relatively to 
endogenous and/or exogenous reference genes. To date, no general agreement between 
different normalization strategies has been found, in particular in cardiac tissue, for the 
study of AF. For these reasons, a preliminary study aiming to establish the best 
endogenous reference genes for miRNAs data normalization was performed. 
Specifically, different well-established analysis tools such as NormFinder, GeNorm, 
BestKeeper and ∆Ct method, were applied on five commonly used endogenous 
reference transcripts such as 5S, U6, SNORD48, SNORD44 and miR-16. The suitable 
reference gene obtained, SNORD48, was applied for miRNAs data normalization. Our 
findings revealed that miRNAs expression levels were different in AF compared to SR 
patients. MiR-208a and miR-208b displayed statistically significant differences between 
the two populations. To investigate possible relationships between miRNAs expression 
levels and the fibrotic content a correlation measurement was also performed. Our 
analysis revealed that miR-21 and miR-208b were close to a significant correlation with 
fibrosis. In conclusion, this work introduced new techniques and implemented new 
methods of analysis for the study of the substrate of AF. In particular, the results 
obtained with this multiscale approach, from structural to molecular level, exacerbated 
the role of fibrosis as a critical contributor in the formation of a pro-arrhythmic 
substrate. Nonetheless, further studies are needed for a better understanding of the ways 
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in which structural, molecular and also cellular remodeling may alter the impulse 
propagation in the myocardium. 
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CHAPTER 1. INTRODUCTION 
 
Atrial Fibrillation: an overview 
 
Atrial fibrillation (AF) constitutes the most frequent arrhythmia worldwide as well as 
the most frequent complication following cardiac surgery, which contributes 
significantly to patient morbidity and mortality. AF is associated with hemodynamic 
instability, prolonged hospital stay, an increased risk of stroke and congestive heart 
failure (CHF), leading to elevated costs for healthcare and medical treatments. 
 
AF is a multi-factorial disorder (Maesen et al., 2012). The mechanisms underlying AF 
occurrence and maintenance are complex and poorly understood. Despite this, during 
the last decades, numerous progresses have been made in understanding its 
pathophysiology (Nattel, 2002; Iwasaki et al., 2011; Wakili et al., 2011). 
Epidemiological data evidenced a rising global incidence of AF, thereby posing this 
condition as an epidemic burden (Chugh et al., 2014). In 2010, the estimated number of 
individuals globally affected by AF was 33.5 million, with 5 million of new cases per 
year (Chugh et al., 2014). AF is increasing with the age of the population, ranges from 
0,1% in the under 55 to 9% in the population aged 80 or older (Go et al., 2001). AF 
incidence resulted higher in man than in women, in particular in the developed 
countries (Kannel et al., 1998; Chugh et al., 2014). The American College of 
Cardiology (ACC) in collaboration with the American Heart Association (AHA) and 
the European Society of Cardiology (ESC), proposed a classification system for AF in 
order to simply and clarify its heterogeneous clinical features (Fuster et al., 2006). 
According to this system AF is classified in three main forms: paroxysmal, persistent 
and permanent. The paroxysmal form occurs periodically and it is able to self-terminate 
within 7 days. Persistent AF usually lasts for more than 7 days and medical treatments 
are needed to terminate the arrhythmia. In permanent AF, which is irreversible, the 
sinus rhythm cannot be sustained by pharmacology or cardioversion but it needs further 
medical treatments. AF occurrence usually initiates as paroxysmal. It may subsequently 
evolve into persistent or permanent forms (de Vos et al., 2010) through a process 
known as remodeling, which implicates electrical and structural changes in the atrial 
tissue (Nattel & Harada, 2014). AF is frequently underestimated because it may occur 
in asymptomatic form. Conversely, patients who manifest AF usually present 
symptoms as palpitations, weakness, fainting, fatigue, dizziness, breath shortness, 
angina (Fuster et al., 2006). The factors which lead to AF may be classified as acute 
factors, which usually derived by the surgical intervention, and chronic factors, which 
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are related to the structure of the heart (Maesen et al., 2012). Among the numerous 
factors predisposing to AF, it is also possible to distinguish between genetic 
determinants, extra-cardiac factors and underlying heart diseases (Wakili et al., 2011). 
Several strategies are currently available to treat AF, all of which aim to restore the 
normal sinus rhythm, controlling the ventricular rate and preventing thromboembolism 
and stroke (Prystowsky, 2000). Different approaches are usually applied to treat AF. 
They may be divided in two main categories: pharmacological and non-
pharmacological. Pharmacological treatments refer to class I and class III anti-
arrhythmic drugs, digitalis, β-blockers and Ca2+ antagonists. On the other side, non-
pharmacological treatments include a series of procedures as catheter ablation, pacing, 
the application of implantable devices as well as different surgery procedures (“Maze” 
procedure or left atrial appendectomy). Pharmacological approaches are generally 
preferred due to their non-invasive properties and are considered first-line intervention 
in AF management. However, they are still a matter of concern due to their side effects 
(Dobrev & Nattel, 2010). 
 
Over the last decades, the management of cardiac arrhythmias has advanced 
enormously due to the numerous efforts in clinical research and biomedical 
technologies. Genetics and molecular biology studies have identified mutations, gene 
variants and new proteins (Mahida et al., 2011; Sinner et al., 2011; Tucker & Ellinor, 
2014) involved in the occurrence of AF, opening new possibilities for the treatment of 
arrhythmia. Medical technologies have improved new imaging systems as well as non-
invasive diagnostic tools; new pharmacological molecules, as well as biological 
therapies, have been discovered and developed in order to minimize pro-arrhythmic 
risks, thus increasing efficacy and safety (Nattel et al., 2014). All these approaches may 
offer many advantages, firstly improving the quality of life and also the economic 
outcomes. Nonetheless, it is well accomplished that any intervention in the treatment of 
AF has to be accurately designed, taking into consideration the underlying clinical 
situation for each patient examined. 
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Mechanisms of AF 
 
Basis of the cardiac action potential 
 
The classical electrophysiological behaviour of the heart consists in the propagation of 
the electrical impulses in an orderly way, causing rapid depolarization and slow 
polarization. These phenomena are able to generate action potentials in cardiac cells. 
Cardiac action potential reflects the modifications of transmembrane potentials which 
are determined by the inward (depolarizing) and outward (repolarizing) currents. 
 
In normal condition cardiac action potential (AP) lasts from 200 to 400 hundred 
milliseconds and consist of five phases: Phase 0, Phase 1, Phase 2, Phase 3, and Phase 
4. During phase 0 a rapid depolarization occurs due to a massive inward current carried 
by voltage-gated sodium channels (INa). This phase is followed by the inactivation of INa 
as well as the activation of the transient outward potassium current (Ito), which cause an 
early repolarization (Phase 1). During phase 2 the repolarization process continues. 
During this stage, the inward L-type calcium current (ICaL) counteracts with a gradually 
increasing the outward repolarizing potassium currents, which are mainly composed of 
the rapid delayed rectifier potassium current (IKr). This phase represents the classical 
“plateau” in the cardiac AP. During phase 3 both IKr and slow delayed rectifier 
potassium current (IKs) contribute to terminate the repolarization. Subsequently, cardiac 
cells return to resting potential (Phase 4).  
Pathophysiology of AF 
AF is a complex phenomenon, so to better understand the underlying mechanisms it is 
necessary to illustrate its pathophysiological context. 
It is well recognized that atrial ectopic activity, as well as the formation of single or 
multiple reentry circuits, represent the main pathophysiological mechanisms of AF 
occurrence and maintenance.  Normal atrial cells action potential stays at the resting 
phase after repolarization. In some circumstances Na
+
 or Ca
2+
 inward currents may 
increase over the time, thus depolarizing cardiac cells; on the other side, K
+
 currents 
may also decrease causing cell repolarization. In this context, cells that reach threshold 
potential may be fired producing atrial automaticity. An ectopic atrial activation is the 
result of an automatic firing that occurs before a normal beat. Delayed 
afterdepolarizations (DADs) represents the most important mechanism of focal atrial 
arrhythmias. They result from an abnormal diastolic leak of Ca
2+
 from the sarcoplasmic 
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reticulum (SR), the main cardiomyocytes Ca
2+
 storage organelle. Ca
2+
 enters 
cardiomyocytes by voltage-dependent Ca
2+
 channels (phase 2), which in turn triggers 
Ca
2+
 release through the SR via ryanodine receptors 2 (RyR2). After action potential 
repolarization Ca
2+
 is removed from the cytosol to the SR by the pump SR Ca
2+
ATPase 
(SERCA), thus diastolic relaxation occurs. DADs represent the consequence of an 
excessive diastolic leak of Ca
2+
 from the SR to the cytoplasm through RyR2 (Dobrev et 
al., 2011). The excess of diastolic Ca
2+
 is handled by the Na
+
, Ca
2+
-exchanger (NCX) 
which transports three Na
+
 ions into the cell per single Ca
2+
 ion extruded. In this case, a 
depolarizing current is produced causing DADs. DADs that reach potential threshold 
cause ectopic firing. Another mechanism that generates ectopic atrial activation is 
represented by early afterdepolarizations (EADs), which is due to inward Ca
2+
 currents 
during ADP prolongation. Reentry circuits require a trigger and a vulnerable “substrate” 
for the initiation. A trigger is generally represented by a premature ectopic beat, while 
the substrate is characterized by electrical and structural alterations of the cardiac tissue 
architecture. Cardiac tissue presents a discrete refractory period (an interval during 
which the tissue is not excitable until the second stimulus). If an ectopic beat reaches a 
still refractory region it will not be able to propagate throughout the tissue; on the 
contrary, if enough time has gone for the recovery of the excitability region, the impulse 
can re-enter causing the activation of the tissue. It is accomplished that shorter 
refractory period (allowing faster recovery of excitability) and/or slower conduction 
velocity (gaining more time for the non-refractory region to regain excitability) may 
favor the maintenance of reentry. Reentry may manifest either as single or multiple-
circuit form. 
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Atrial Remodeling 
 
To date, several experimental and clinical studies have demonstrated that during AF 
occurrence the properties of the cardiac tissue change over time, thus increasing the 
likelihood of ectopic or reentrant activities which sustained AF itself (Nattel & Harada, 
2014). Collectively these changes referred to the phenomenon of atrial remodeling 
(Allessie et al., 2002; Nattel et al., 2008). 
Electrical remodeling 
 
AF modifies the electrophysiological properties of the atrial tissue by altering ion 
channels/transporters expression and/or their functions (Schotten et al., 2011). The 
abbreviation of the atrial effective refractory period (AERP) accompanied with the loss 
of the physiological rate adaptation, represent the major consequences of this 
phenomenon which is termed electrical remodeling (Wijffels et al., 1995; Brundel et 
al., 2001). AF-induced electrical remodeling has been recently indicated as atrial 
tachycardia remodeling (ATR). 
The reduction of the L-type Ca
2+
 current (ICaL) and the enhancement of the inward 
rectifier K
+
 currents, such as the background current (IK1) and the constitutively 
acetylcholine-regulated K
+
 current (IKACh) (Cha et al., 2006; Dobrev et al., 2001; 
Dobrev et al., 2005), are the main components of the electrical remodeling. In addition, 
an abnormal expression and distribution of the gap junction connexin hemichannels, has 
also been observed (Nattel & Harada, 2014). 
The rapid increase of the atrial rate (tachycardia) with the onset of AF causes a massive 
Ca
2+
 influx into cardiomyocytes. To prevent potentially cytotoxic effects, 
cardiomyocytes respond by reducing the inward Ca
2+
 current ICaL which causes ADP 
and wavelength shortening, thus creating a substrate for AF maintenance (Nattel, 2002). 
At the initial phase, the ADP reduction is a consequence of IcaL inactivation. On the 
contrary, when AF is sustained, the decrease of ICaL may result by the downregulation 
of the pore-forming Ca
2+
 channels subunit (α-subunit) (Yue et al., 1999) and also by 
posttranslational mechanisms, such as protein dephosphorylation and breakdown 
(Christ et al., 2004; Brundel et al., 2002). It has also been demonstrated that an 
impairment in intracellular Ca
2+
 handling may cause loss of ADP rate dependence, thus 
predisposing to AF occurrence (Kneller et al., 2002). 
Some investigators have demonstrated that ATR reduces the expression of Cav1.2 α-
subunit (Brundel et al., 2001; Yue et al., 1999) whereas others have not observed any 
16 
 
modification. In addition, other studies indicated a reduction in the expression of β1, β2a, 
β2b, β3 and α2δ2 accessory ICaL subunits (Christ et al., 2004; Gaborit et al., 2005; Greiser 
et al., 2007; Schotten 2003). It has also been observed that due to a reduction in the 
endogenous expression of glutathione (Carnes et al., 2007), Cav1.2 S-nitrosylation 
resulted increased in AF. This highlight the importance of the oxidative stress in IcaL 
changes. In addition, it has been observed an increase in the expression of ZnT-1 (a 
protein associated with Zn homeostasis) in ATR, resulting in IcaL suppression (Beharier 
et al., 2007). Nonetheless, ICaL dysregulation may derived by an impairment in tyrosine 
kinases activities (Greiser et al., 2007).  
The resting membrane potential of cardiomyocytes is maintained by K
+
 currents 
(inward rectifiers), which becomes more negative during AF. In particular, IK1, which is 
composed primarily of Kir2.1 subunits, has been indicated as one of the most important 
determinants of AF-maintaining reentry (Pandit et al., 2005) and it is up-regulated in 
AF (Wakili et al., 2011). Another important inward-rectifier K
+
 current is represented 
by IKACh, which mediates cardiac vagal effects. The release of acetylcholine from the 
vagal nerve endings activates IKACh, causing the abbreviation of the ADP and the cell-
membrane hyperpolarization (Nattel et al., 2008). The increase of vagal activity may 
promote AF by stabilizing reentry circuits (Kneller et al., 2002). ATR modifies the 
IKACh system in a way that agonist-stimulated IKACh (vagal activation) is decreased, 
while its constitutively form IKACh,c is increased (Cha et al., 2006; Dobrev et al., 2005; 
Ehrlich et al., 2004; Voigt et al., 2008). Some studies indicate that the enhancement of 
IKACh,c derived by an increase in single-channel open probability, is a consequence of 
slowed channel closure (Voigt et al., 2008). In this regard, some investigators observed 
that in ATR models (Ehrlich et al., 2004; Voigt et al., 2008) mRNA and protein levels 
of Kir3 subunits (which underlying IKACh) remained unvaried; on the contrary, in human 
patient with chronic AF they were decreased (Dobrev et al., 2005). It has also observed 
that during AF there is an up-regulation of protein kinase C (PKC) (Voigt et al., 2007), 
suggesting that an increase in PKC-mediated phosphorylation may play an important 
role in IKACh,c enhancement. Some studies have also demonstrated that the blockage of 
IKACh,c suppresses the ADP abbreviation, decreasing AF occurrence (Cha et al., 2006), 
thus placing IKACh,c among the important players of arrhythmias. 
A consistent reduction of the transient outward K
+
 current (Ito) has been observed in 
ATR (Nattel et al., 2007). Despite the functional consequences of its down-regulation 
remain to be clarified, it is accomplished that Ito activation is fast and produces an 
outward current which opposes the inward Na
+
 current during the initial phase of the 
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cardiac action potential. As a consequence, Ito downregulation may affect wave 
propagation by increasing the action potential amplitude. 
It has been observed that the decrease of Ito parallels the downregulation of the pore 
forming Kv4.3 α-subunits, both at mRNA and protein expression level (Yue et al., 
1999). In this regard, the activation of Ca
2+
-dependent protein phosphatase calcineurin 
(Rossow et al., 2006) as well as the proteolytic activity mediated by calpains (Brundel 
et al., 2002; Goette et al., 2002), may have a significant role in suppressing Kv4.3 gene 
transcription and protein degradation, respectively. 
The information regarding IKur modifications during AF occurrence result inconsistent 
(Nattel et al., 2007). However, it is accomplished that its role in atrial repolarization is 
strongly dependent on the action potential morphology (Courtemanche et al., 1999). 
Nevertheless, due to its atrial specificity, IKur still remains an attractive therapeutic 
target for AF treatment (Nattel, 2002). 
IKr and IKs delayed-rectifier currents resulted unchanged in ATR experimental models, 
while in humans there is a lack of information in the field due to experimental technical 
difficulties (Yue et al.,1996). 
 
 
Structural remodeling 
 
Numerous evidence indicate that structural remodeling represents an important 
contributor  to the formation of the AF substrate (Burstein & Nattel, 2008). 
 
Structural remodeling is a slower process compared to electrical remodeling, which 
comprises numerous morphological changes of the atrial myocardial tissue structure and 
architecture (Corradi et al., 2008; Nattel et al., 2008). In this regards, it has been 
demonstrated that a combination of atrial enlargement with atrial fibrosis, creates longer 
potential conduction pathways for reentry, slows conduction and also imposes 
conduction barriers,  leading to the formation of reentry circuits that sustained AF itself 
(Nattel et al., 2008). The exact regulatory mechanisms underlying atrial extracellular 
matrix (ECM) remodeling as well as the precise signaling pathways which lead to 
structural changes, have not been completely elucidated. Despite this, it is well 
accomplished that several secreted factors are involved in the profibrotic process, many 
of which act both at a single level and synergistically (Katz, 2002). 
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Genetic contributors to atrial fibrillation 
 
 
AF mechanisms include also a genetic component, characterized by a complex 
background that involves numerous pathways (Mahida & Ellinor, 2012). The way to 
unravel the genetic basis of AF has progressed from the identification of genes 
associated with familial AF to clinical observational studies, thus demonstrating its 
hereditability. In addition, over the last decade, genome-wide association studies 
(GWAS) have identified hundreds of new genetic association, involving common single 
nucleotide polymorphisms (SNPs).  
Despite the complex and aging-related clinical risk factors AF is hereditable. In this 
context, the Framingham study indicated that parental AF increased the risk of AF in 
offspring (Fox et al., 2004). In addition, a study performed by Ellinor and coworkers 
reported that lone AF (without apparent structural heart diseases) increases the risk of 
AF in family members (Ellinor et al., 2005). 
Linkage studies and candidate gene searches allowed for the identification of numerous 
ion channel gene mutations. In this context, mutations in the potassium channel (e.g. in 
KCNQ1, KCNE2, KCNH2, KCNJ2, KCNA5) (Das et al., 2009; Hong et al., 2005; 
Makiyama et al., 2008; Xia et al., 2005; Yang et al., 2004) and in the sodium channel 
(in SCN5A and SCN4B) (Benito et al., 2008; Li et al., 2013) have been associated with 
familial AF. Several non-ion channel genes have also been associated with familial 
monogenic AF. Among these genes PRKAG, that is associated with familial Wolff-
Parkinson-White syndrome and AF (Gollob et al., 2001) and NPPA, that encodes for 
atrial natriuretic peptide (Hodgson-Zingman et al., 2008, Disertori et al., 2016), have 
been found. Additionally, some developmental genes, such as genes encoding 
transcription factors involved in cardiogenesis from the GATA family (Posch et al., 
2010; J. Wang et al., 2012; Wang et al., 2013) and NKX2-5, have been implicated in 
AF (Huang et al., 2013). Structural genes, such as  GJA5, which encode for connexin 
40, and RYR2, which encodes for the ryanodine receptor releasing intracellular stores 
of calcium, have also been associated with familial AF (Gollob et al.,2006; Kazemian et 
al., 2011). Further, some genes encoding nuclear membrane-associated proteins, such as 
LMNA, which encodes for lamin expressed in the inner nuclear lamina (Beckmann et 
al., 2010) and NUP155, which encodes for a nucleoporin (Zhang et al., 2008), have 
been linked to familial AF.  
Despite the studies about familial AF have greatly improved the understanding of genes 
associated with AF monogenic forms, they constitute only a fraction of the global 
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burden. Complex diseases, such as AF, follow the "common disease common variant" 
hypothesis, which predicts that common variants with small effects appear to be 
responsible for a majority of the heritability of the traits (Manolio et al., 2009).  
In this context, GWAS allowed for the identification of 14 AF-associated genetic loci to 
date, thus overcoming possible biases deriving from candidate gene analysis 
(Deshmukh et al., 2015; Ellinor et al., 2012; Sinner et al., 2014). In particular, the first 
GWAS study, performed in 2007, identified a susceptibility locus at chromosome 4q25 
in a population of European descent as well as in an Asian population (Gudbjartsson et 
al., 2007). The region around the 4q25 locus has been defined as a ‘genetic desert’, with 
the closest gene (PITX2) located 150000 base pairs upstream. PITX2 encodes for the 
paired-like homeodomain transcription factor 2 with 3 different isoforms. Importantly, 
the PITX2c isoform is the major expressed in the heart (Franco et al., 2012). PITX2 is 
involved in the embryonic cardiogenesis, where it is crucial to right–left asymmetry, in 
terms of the suppression of the formation of a sinus node in the left atrium and the 
formation of the myocardial sleeves in the pulmonary veins (Mommersteeg et al., 
2007). Studies on knockout and haploinsufficient PITX2 mice, have revealed a 
predisposition to atrial arrhythmias (Wang et al., 2010) and AF (Kirchhof et al., 2011). 
In humans and mice, it has been observed that the depletion of PITX2c reduces the 
levels of mRNA encoding sodium and potassium channel protein subunits, suggesting 
this gene as an upstream transcriptional regulator of atrial electrical function (Chinchilla 
et al., 2011; Tao et al., 2014). 
GWAS studies have also identified numerous other loci associated with transcription 
factors that seem to be important for cardiac development. Specifically, ZFHX3 which 
is located on chromosome 16q22, intronic to the zinc finger homeobox 3 gene, is known 
to be involved in the regulation of growth and differentiation of skeletal muscle and 
neuronal tissues (Benjamin et al., 2009). ZFHX3 is necessary for the transcriptional 
activation of the gene POU class I homeobox 1 (POU1F1), that interacts with PITX2, 
allowing DNA binding and transcriptional activity (Liu et al., 2012). Another GWAS 
study described the gene PRRX1, that encodes for a homeodomain transcription factor 
present in the connective tissue in the developing heart (Ellinor et al., 2012). In 
particular, knockout animal models of PRRX1 have shown impairments in the 
pulmonary vasculature (Ihida-Stansbury et al., 2004).  
Hitherto, two loci in ion channel genes have been significantly associated with AF in 
GWAS. First, a locus was identified on chromosome 1q22 within an intron of the 
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KCNN3 gene, that encodes for the calcium-activated potassium SK3 (Ellinor et al., 
2010). Second, a locus was described on chromosome 15q24, within an intron on the 
hyperpolarization-activated cyclic nucleotide-gated 4 (HCN4) gene (Ellinor et al., 
2012). HCN4 is present in the sinoatrial node and regulates the If current, which is 
responsible for the pacemaker current in nodal myocytes. Mutations of this channel may 
cause diminished action potential frequency and delayed after depolarizations, thus 
leading to AF (Macri et al., 2014).   
A meta-analysis of GWAS performed in 2010 identified numerous new AF loci, 
including three within/close to genes that are involved in cellular structural components. 
In particular, a locus on chromosome 7q31 within an intron of the gene CAV1, that 
encodes caveolin-1, was associated with AF (Ellinor et al., 2012). CAV1 is co-expressed 
with a potassium channel gene (KCNH2), which is involved in the repolarization phase 
of the action potential. The risk allele and AF are associated with decreased expression 
of  CAV1 (Martin et al., 2015). In addition, caveolin-1 has been postulated as an anti-
fibrotic factor in atrial tissue, since down-regulation of Cav-1  results in an increase of 
TGF-β1, leading to the activation of the Smad signal pathway and to the production of 
collagen (Yi et al., 2014).  
A SNP located within an intron of the SYNE2 gene, that encodes for nesprin-2, a protein 
that anchors nuclei to the cytoskeleton, has also been associated with AF. A wide meta-
analysis of GWAS performed by Ellinor and colleagues identified a susceptibility locus 
on chromosome 10, between SYNPO2L and MYOZ1 genes, and another locus in an 
open-reading frame on chromosome 9 (C9orf3) (Ellinor et al., 2012). MYOZ1 encodes 
for a protein which is involved in stabilizing the sarcomere, while C9orf3 is associated 
with three coding genes (including FBP1 and FBP2), that are involved in 
gluconeogenesis (Ellinor et al., 2012). 
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Atrial fibrosis & Atrial Fibrillation 
 
Although not exclusively related to AF, fibrosis constitutes a common feature in AF 
representing one of the most important contributors to arrhythmogenesis (Schotten et 
al., 2011). Atrial fibrosis has been observed in lone AF (Boldt et al., 2004; Frustaci et 
al., 1997) as well as in other pathological conditions associated with AF, such as 
congestive heart failure (Burstein et al., 2009; Li et al.,1999), rheumatic heart disease 
(Xiao et al., 2010), valvular disease (Anné et al., 2005), dilated and hypertrophic 
cardiomyopathy (Ohtani et al., 1995; Prinz et al., 2011) and senescence (Gramley et al., 
2009). However, some experimental and clinical studies have demonstrated beneficial 
effects both in AF stability and in atrial structural remodeling by the administration of 
compounds with known anti-fibrotic effects, as Angiotensin II type 1 receptor blocker 
(Kumagai et al., 2003), statins (Li et al., 2001; Shiroshita et al., 2007) and omega-3 
polyunsaturated fatty acids (Sakabe et al., 2007). Collectively, this evidence suggest an 
association between atrial fibrosis and AF. In addition, it is well accomplished that AF 
itself may promote atrial fibrosis, which in turn sustains AF (Burstein & Nattel, 2008; 
Yue et al., 2011). 
 
Atrial fibrosis is a complex phenomenon, which is characterized mainly by an excessive 
accumulation of ECM proteins, secreted primarily by myofibroblasts (myoFBs) (the 
activated form of cardiac fibroblasts, under pathological conditions)(Burstein & Nattel, 
2008; Yue et al., 2011). Fibrosis can be a reparative or a reactive process. During 
reparative fibrosis, the cardiac tissue architecture is maintained by the replacement of 
dead cardiomyocytes. On the contrary, under pathological conditions, reactive fibrosis 
causes the accumulation of ECM components leading to interstitial expansion and 
muscle bundles separation (Burstein et al., 2008; Yue et al., 1999). The resultant 
fibrotic tissue creates a barrier that interferes with the normal electrical impulse 
propagation, leading to conduction abnormalities as arrhythmogenesis (Li et al., 1999). 
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Molecular mechanisms leading to atrial fibrosis 
 
The exact molecular mechanisms underlying atrial fibrosis, in particular regarding the 
ECM formation, remain to be clarified. Nonetheless, a growing body of evidence has 
indicated that numerous factors (secreted both by cardiomyocytes and cardiac 
fibroblasts) and signaling pathways are involved in this process (Burstein & Nattel, 
2008) (Figure A). 
 
Angiotensin II (Ang II) is considered one of the most potent pro-fibrotic molecules and 
has been demonstrated to have an important role in AF (Ehrlich et al., 2006). Ang II 
binds to two distinct receptor subtypes: angiotensin type I (AT1R) and angiotensin type 
II (AT2R) receptors. Both receptors present different signaling cascades with opposite 
effects. The activation of AT1R by Ang II stimulates fibroblasts proliferation, 
cardiomyocytes hypertrophy and apoptosis (Burstein & Nattel, 2008). The AT1R, 
through the Shc/GRb2/SOS adapter-protein complex, activates the GTPase protein RAS 
that initiates a series of mitogen-activated protein kinase phosphorylation cascades, 
which are important in the remodeling process (Hunyady & Catt, 2006). The mitogen 
activated protein kinases ERK (extracellular signal-related kinase) -1 and -2, JNK (c-
Jun N-terminal kinase) and p38, activate transcription factors as Elk-1, c-jun and c-fos 
that modulate gene expression. The activation of AT1R also stimulates phospholipase 
C, which breaks down the membrane phosphoinositol bisphosphate (PIP2) into 
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG, by the activation of 
the PKC, and IP3, by increasing intracellular Ca
2+
 release, promote remodeling. In 
addition, the signal occurs through the JAK/STAT pathway that activates transcription 
factors, such as the activator protein 1 (AP-1) and the nuclear factor-kB (NF-kB).  
The activation of AT2R inhibits mitogen-activated protein kinases (MAPK) (Hunyady 
& Catt, 2006) by phosphotyrosine phosphatase (PTPs) and protein phosphatase 2A 
(PP2A), leading to anti-proliferative effects. The balance between ATR1 and ATR2 
could have important implications for the treatment of AF.  
Transforming Growth Factor β1 (TGF-β1) is a molecule secreted by both 
cardiomyocytes and fibroblasts which may be considered the primary downstream 
mediator of Ang II, either in autocrine and paracrine modes. Ang II induces TGF-β1 
synthesis, which stimulates fibroblasts activity. In turn, TGF-β1 enhances Ang II and 
the production of other pro-fibrotic factors creating a positive feedback (Rosenkranz, 
2004). TGF-β1 also stimulates fibroblast activation and collagen deposition via SMAD 
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protein (Attisano & Wrana, 2002). Some studies revealed that cardiac overexpression of 
constitutively active TGF-β1 causes selective atrial fibrosis and atrial conduction 
heterogeneity, thus predisposing to AF (Verheule et al., 2004). Platelet-Derived Growth 
Factor (PDGF) is one of the numerous growth factors which stimulates fibroblasts 
proliferation and differentiation. After the binding of the ligand, the PDGF receptors 
dimerize leading to the activation of a tyrosine kinase, which in turn forms part of the 
receptor itself. This tyrosine kinase phosphorylates intracellular domains of the PDGF 
receptor. The autophosphorylation activates the PDGF receptors, leading to the 
activation of a signaling pathway via mitogen-activated protein kinase JAK/STAT and 
phospholipase C (shared with TGF-β1 and Ang II). In addition, also PDGF seems to 
underlie fibroblast hyperresponsiveness, thus explaining the higher susceptibility of the 
atria with respect to the ventricles in the fibrotic remodeling process (Burstein et al., 
2008). CTGF belongs to the CCN (cyr61, ctgf, nov) protein family and it is known to be 
the major downstream effector of the TGF-β1 in the fibrotic process. CTGF directly 
activates fibroblasts (Ahmed et al., 2004) and it is up-regulated by both Ang II (Ahmed 
et al., 2004) and TGF-β1 (Chen et al., 2000). 
 
The process of cardiac structural remodeling comprises numerous factors involved not 
only in the synthesis of the ECM components but also in their degradation. In this 
context, matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play a critical 
role in the maintenance of the ECM homeostasis (Kakkar & Lee, 2010). MMPs 
represent a family of zinc-dependent endopeptidases, which are responsible for ECM 
degradation. An anomalous increase in MMPs activity causes the degradation of matrix 
proteins (D’Armiento, 2002; Li et al., 2000; Thomas et al., 1998), while TIMPs inhibit 
the proteolytic activity of MMPs by establishing tight-binding complexes (Gomez et 
al.,1997). It has been observed that both the expression and the activity of cardiac 
MMPs increase in numerous pathological conditions, including heart failure and 
myocardial infarction (Cleutjens, 1995; Spinale et al., 2000; Sutton & Sharpe, 2000). 
Recently, many evidence in humans and animal models have shown an unbalance 
between MMPs and TIMPs expression in atrial fibrillation. Specifically, matrix 
metalloproteinase-9 was found up regulated and TIMP-1 was down-regulated in dogs 
with atrial fibrillation, compared to the controls (Zhang et al., 2008). In addition, 
another study performed on canine animal models revealed an increase of the activity of 
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MMP-9 (~50%), paralleling a decrease of TIMP-4 (~50%), after rapid atrial pacing-
induced heart failure (Hoit et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A: Molecular mechanisms leading to atrial fibrosis. Major profibrotic signaling 
pathways involved in fibrosis (modified from Wakili et al., 2011). 
 
 
Extracardiac factors involved in atrial fibrosis 
 
Several extracardiac factors have been indicated to predispose to fibrosis in AF. Diabetes, 
obesity, metabolic syndrome, systemic inflammation, obstructive and central sleep apnea, 
athlete’s heart, hyperthyroidism and the use of toxic substances, have all been demonstrated 
to affect the myocardium (Schoonderwoerd et al., 2008). Diabetes, which is known to be 
associated with cardiomyopathy and cardiac fibrosis, has been recently indicated to triple 
the risk of AF in obese individuals (Grundvold et al., 2015). Obesity causes electrical and 
structural modifications of the myocardium, leading to delay and heterogeneity in atrial 
conduction, inflammation and fibrosis. The pathways underlying these processes comprised 
TGF-β1 signaling activation, oxidative stress and the up-regulation of PDGF and endothelin 
(Abed et al., 2013). Obstructive and central sleep apnea are also associated with atrial 
remodeling and AF (Matassini el al., 2015). In this context, animal studies of obstructive 
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sleep apnea showed a substantial down-regulation of connexin43 associated with an 
altered expression of ion channels proteins, resulting in shortening of the atrial 
refractory period, slowing conduction, cardiomyocytes apoptosis and cardiac fibrosis 
(Iwasaki et al., 2014). 
 
 
 
26 
 
Extracellular matrix remodeling in atrial fibrosis: the collagen fibers 
network 
 
The cardiac ECM represents the three-dimensional scaffold that defines the geometry 
and the muscular architecture of the cardiac chambers. It is an active system able to 
respond to different mechanical stresses and numerous external stimuli, as 
neuroendocrine activation, growth factors and cytokines. 
 
The formation and redistribution of connective tissue fibers modulate the geometry of 
the myocardium in order to adapt to the physiological conditions, thus preventing (or 
attenuating) the effects of new electrical, mechanical and chemical stimuli. 
 
Collagen fibers, the major components of the cardiac ECM, are normally associated 
with the maintenance of the tissue structure architecture. A large number of 
cardiovascular disorders, including myocardial infarction, hypertension, and heart 
failure are related to alterations in the amount, type, stability and organization of 
collagen fibers (Ju & Dixon, 1996). In addition, it has been shown that during 
pathological conditions collagen fibers undergo both qualitative and quantitative 
modifications, leading to an excessive accumulation either in regions of cardiomyocytes 
loss (as in reparative fibrosis) or diffusely (as in dilated cardiomyopathy and reactive 
fibrosis)(Tarone et al., 2014). 
 
The global accumulation of collagen fibers impairs the mechanical properties of the 
myocardium causing an increase in the wall stiffness, resulting in less compliant 
chambers which may predispose to arrhythmogenesis. 
 
The collagen fibers network of the heart: structural architecture 
 
Myocardial ECM is composed primarily of a complex network of fibrillar collagen 
(Caulfield & Borg, 1979). The spatial organization of collagen in the heart has been 
described by the detailed organization of layers that surround and interconnect both 
individual and groups of cardiomyocytes (Robinson et al., 1983). Specifically, from the 
outer to the inner side it is possible to find: the epimysium, the perimysium and the 
endomysium, respectively. The epimysium is the connective tissue that surrounds all of 
the cardiomyocytes bundles in the myocardium. The perimysium represents the sheath 
of connective tissue that surrounds and interconnects groups of cardiomyocytes, in a 
particular orientation. The endomysium constitutes the inner matrix element that 
surrounds individual cardiomyocytes, within each bundle. While the epimysium and the 
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perimysium are composed primarily of fibrillar collagen, the endomysium represents a 
complex network of collagen and elastin. The general content and structure of these 
elements are believed to be involved in the maintenance of the shape and distensibility 
of the cardiac chambers (Weber et al., 1994; Weber, 1989). It has been shown that the 
fibrillar collagen network forms a structural continuum with the fibrous skeleton of the 
entire heart, including cardiac valves, chordate tendinae and the perivascular matrix. 
The perimysium may have a great impact on cardiac performance due to the property to 
interconnect all the contractile elements of the myocardium (Robinson et al., 1983). The 
orientation of the perimysium results altered by the loading conditions of the heart, 
assuming a coiled configuration when relaxed and a linear configuration when stretched 
(Robinson et al., 1988). The fibers that constitute the perimysium are normally oriented 
along the long-axis of the muscle bundles. In addition, they also provide extensive 
branching patterns that link cardiomyocytes all through the myocardium by an 
organized network of fibrillar collagen (Robinson et al., 1987, 1983, 1988). The 
connectivity of the fibrillar collagen network may play an important role in the 
coordination of the whole myocardial contraction. Studies in this field have been shown 
that the myocardium of mammals due to its numerous matrix interconnections, can 
generate a more powerful cardiac contraction compared to a myocardium with poorly 
interconnected perimysial fibers as observed in frog hearts (Factor & Robinson, 1988). 
 
Collectively, this evidence suggests that the contractile ability of the myocardium 
represents an example of biological engineering, made possible by its three-dimensional 
architecture primarily based on the content and organization of the fibrillar collagen 
network. 
 
The collagen fibers network of the heart: synthesis, composition and 
regulation 
 
Collagen is produced by CFs as a precursor, procollagen. It is subsequently converted 
into its mature form by a series of proteolytic reactions (Kagan & Trackman, 1991; 
Prockop & Kivirikko, 1995) followed by post-translational modification, leading to 
intermolecular cross-linking formation between adjacent fibers. Collagen fibers are then 
assembled together, forming larger fibers that are resistant to degradation (Bishop & 
Laurent, 1995). 
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The human heart is primarily composed of types I and types III collagen, accounting for 
the 85% and 15%, respectively. However, collagen types IV, V, VI are also present but 
in a low percentage (Manabe et al., 2002; Weber et al., 1988; Medugorac & Jacob, 
1983). Collagen type I has been associated with thicker perimysial fibers, which play an 
important role in withstanding shear stresses and in coordinating the whole contraction 
(Weber, 1989). On the contrary, collagen type III, which has been associated with 
thinner perimysial fibers, is less rigid and may confer elasticity to the myocardium. 
Despite their exact functional role in the myocardium has never been clearly 
demonstrated, some evidence indicates that the ratio of collagen isoforms may 
influence myocardial compliance and diastolic relaxation (Burgess et al., 1996). In 
particular, some studies indicated an altered proportion of collagen type I respect to 
collagen type III in AF patient, after cardiac surgery (Grammer et al., 2005). The 
content of cardiac collagen in the normal myocardium is around 2-4% (Brower et al., 
2006) with a relatively high turnover, ranging from 1 to 6% per day (Bishop & Laurent, 
1995; Laurent, 1987; Weber & Brilla, 1991). Normally, at the steady state condition 
collagen synthesis and degradation are comparable. Several molecules such as growth 
factors, hormones and cytokines, are involved in the modulation of collagen synthesis. 
Among these, the β-adrenergic system, the renin-angiotensin-aldosterone system 
(RAAS) and the transforming growth factor-β (TGF-β) are indicated to be the most 
important. The β-adrenergic system (Calderone et al., 1998) and the RAAS system 
(Sun et al., 2001) increase cardiac collagen synthesis via G-protein-coupled signaling 
pathways (Meszaros et al., 2000). TGF-β acts by stimulating SMAD and Rho/ROCK 
signaling cascades, resulting in the activation of ECM genes and increasing the 
expression and secretion of growth factors (as connective tissue growth factor, CTGF). 
 
Prior to assembly, about 50% of the fibrillar collagen is degraded inside the cell. 
Fibrillar collagen and other ECM components are normally broken down by MMPs, 
which are released mainly by CFs and also by inflammatory cells and cardiomyocytes 
(Spinale, 2007). Collagenases (MMP-1, MMP-8, MMP-13), gelatinases (MMP-2, 
MMP-9) and stromelysins (MMP-3), are indicated to be responsible for ECM 
degradation (Porter & Turner, 2009). The expression of MMPs is influenced by growth 
factors (such as TGF-β) and cytokines, while their inhibition is mediated by 
Angiotensin II. Despite the importance of biochemical signaling pathways in collagen 
synthesis and degradation, a pivotal role is also determined by mechanical loading 
which is able to modulate myocyte growth as well as the three-dimensional architecture 
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of the ECM. Studies on different tissue samples such as tendon (Canty & Kadler, 2005), 
skin (Armstrong & Ferguson, 1995) and heart valve leaflet (Driessen et al., 2003), 
indicated that load bearing fibrillar collagen align with local directions of principal 
stress. It is also known that the post-natal development growth of myocyte and 
nonmyocyte components (Bernardo et al., 2010), is accompanied by the spatial 
arrangement of collagen fibers network, thus preserving ECM architecture and function. 
During pathological conditions, mechanical stimuli as pressure overload, lead to the 
remodeling of both cellular and acellular myocardial components, thus indicating that 
the myocardium has the capability to sense and respond to differences in mechanical 
loading. As indicated by in vitro studies, fibroblasts (with different tissue origins) 
exposed to mechanical stimulation, increase their proliferation rate, collagen 
production, altered MMPs expression, growth factors and cytokines levels (Thampatty 
& Wang, 2008). Another study indicated that cyclic mechanical deformation of CFs 
gave rise to an increase in collagen production, albeit affected by other matrix 
component and serum growth factors (Butt & Bishop 1997; Carver et al., 1991). The 
exact mechanisms that underlie the mechano-transduction in the ECM are not fully 
elucidated. However, it is accomplished that there are numerous deformation sensors 
coupled to signaling cascades, as stretch-activator ion channels, integrins, cytoskeletal 
structures (Berenji et al., 2005; Ross & Borg, 2001; Thampatty & Wang, 2008), which 
are able to stimulate different ECM components.  
In summary, the cardiac ECM constitutes the scaffold for the three-dimensional 
organization of cardiac cells, as well as for the transmission of forces across the entire 
heart wall. Nonetheless, it represents an active system with the capability to sense 
differences in mechanical loading and consequently, it is also able to adapt to them. 
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MicroRNAs & Atrial Fibrillation 
 
MicroRNAs (miRNAs) represent an evolutionarily conserved class of small (~22 
nucleotides) non-coding RNAs (Ambros, 2004; Gan et al., 2013) first discovered in the 
nematode Caenorhabditis elegans (Ruvkun & Giusto, 1989; Ruvkun et al., 1989). 
 
Virtually expressed in all organisms, miRNAs represent a fundamental component of 
the genetic regulation, suggesting a key role in biological processes (Latronico & 
Condorelli, 2008; Thum et al., 2008). MiRNAs are considered negative regulators of 
gene expression at the post-transcriptional level. They inhibit protein translation and/or 
promote mRNA degradation by base-pairing to complementary sequences within 
mRNA transcripts (Van Rooij & Olson, 2012). 
 
To date, more than 2,500 mature miRNAs have been identified in the human genome 
(www.miRbase.org, Release 21) and over 60% of protein-coding genes have been 
found to be regulated by miRNAs (Friedman et al., 2009). The physiological 
importance of miRNAs has been well documented in numerous biological processes 
such as cellular proliferation, differentiation (Brás-Rosário et al., 2013), tissue 
remodeling (Orenes-Piñero et al., 2013; Xu et al., 2013), tumorigenesis (Dvinge et al., 
2013; Song et al., 2013) and also in cardiovascular diseases (Small et al., 2010). 
Several studies have also indicated an involvement of miRNAs in AF-related 
remodeling processes, suggesting a key role of these small non-coding RNAs in the 
regulation of many signaling mechanisms underlying atrial fibrosis and AF. 
 
Biogenesis and biological action of miRNAs 
 
The maturation process of miRNAs comprises different steps (Bartel, 2004; Cullen, 
2004) that start with the transcription operated by RNA polymerase II of single-stranded 
non-coding RNAs (Figure B). According to the genomic location of the primary coding 
sequences, it is possible to define different types of miRNAs: intergenic miRNAs, 
which are located between genes, and intragenic miRNAs, that are generated by the 
processing of introns in protein-coding genes. Transcription of intergenic miRNAs 
leads to the formation of primary precursors (pri-miRNAs) with a characteristic hairpin 
or “stem-loop” like structure (Denli et al., 2004). The pri-miRNA is subsequently 
processed by an endonucleolytic cleavage into ~70 nucleotide hairpin-shaped precursor 
miRNA (pre-miRNA). The processing of pre-miRNAs from intergenic genomic 
sequences is mediated by the nuclear RNase III Drosha, while the processing of 
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intragenic miRNAs needs additional splicing enzymes. The unique exception is 
represented by one subtype of intronic miRNA (mirtron), which produces its pre-
miRNA by using only a splicing enzyme, in a Drosha-independent manner (Berezikov, 
2011). Pre-miRNAs are then transported by the protein Exportin-5 from the nucleus to 
the cytoplasm (Lund et al., 2004), where they are further process into a mature miRNA 
duplex of ~22 nucleotide length by the RNase III enzyme Dicer (Kim et al., 2009). The 
mature miRNA is then incorporated into the RNA-induced silencing complex (RISC) to 
form miRISC (Gregory et al., 2005). The two miRNA strands, the “passenger” and the 
“guide” strand, are then separated leaving only the guide strand assembled into the 
miRISC complex. The miRISC complex binds to the complementary sequence of the 
target mRNA, usually in the 3’-untranslated region (3’-UTR) (Carthew et al., 2009). 
Despite most miRNA-mRNA binding interactions are not fully complementary, a 
perfect match between the miRNA “seed region” (2-8 nucleotides in the 5’-end) and the 
target mRNA is believed to be required for miRNA action. Possibly according to the 
degree of complementarity between miRNAs and their target mRNAs, miRNAs can 
inhibit the translation of the encoded proteins or lead to mRNA degradation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B: Biogenesis and action of miRNAs (Luo et al., 2015). 
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MiRNAs expression profile in the heart 
 
The normal myocardium presents a distinct pattern of miRNAs, which is different from 
other organs (Liang et al., 2007). Studies revealed that the top 20 most abundant 
miRNAs expressed in the human heart are: miR-1, miR-133a/b, miR-26a/b, miR-
125a/b, let-7a/b/c/f/g, miR-16, miR-100, miR-126, miR-145, miR-195, miR-199, miR-
20, miR-21, miR-23, miR-24, miR-29a/b, miR-27a/b, miR-30a/b/c, miR-92a/b, and 
miR-99 (Liang et al., 2007). The majority of these miRNAs are also expressed in 
different organs, apart for miR-1 and miR-133a/b that are preferentially expressed in 
cardiac and skeletal muscle (Chen et al., 2006). In addition, other medium-expressed 
miRNAs such as miR-208a/b and miR-499, are found to be cardiac-specific (Van Rooij 
et al., 2007). 
 
 
Functions of miRNAs in AF 
 
MiRNAs involved in electrical remodeling 
 
As already mentioned, arrhythmogenesis is generally attributed to enhanced trigger 
activity, which may result in alterations in different ion channels as well as impairment 
in Ca
2+
 handling (Ter Keurs & Boyden, 2007) and modulation of the cardiac inwardly 
rectifying K+ current (IK1) (Dhamoon & Jalife, 2005).  
miRNAs play an important role in the functional control of ion channel genes during 
electrical remodeling (Luo et al., 2010), thus contributing to AF progression (Figure C). 
Studies in the field, have shown an inverse correlation between the expression of miR-1 
and the distribution of inward rectifying potassium channel (Kir2), in left atrial tissue 
patient with persistent AF. In particular, it has been observed a downregulation of miR-
1 by 86% accompany with a high expression of Kir2, which represents an important 
factor in AF maintenance (Girmatsion et al., 2009). miR-1 has also been suggested to 
have a mechanistic importance in AF pathophysiology, via targeting both IK1 and 
connexin43 (Girmatsion et al., 2009; Yang et al., 2007), that are considered key 
regulators of cardiac conduction. It has also been proposed an involvement of miR-1 in 
the modulation of Ca
2+
 handling. Specifically, miR-1 causes the hyperphosphorylation 
of RyR2, enhancing its activity, thus promoting arrhythmogenic SR Ca
2+
 release 
(Terentyev et al., 2009). In a similar way, also miR-26 has been shown to repress IK1 
(Luo et al., 2013). The transcription of miR-26 is negatively controlled by the 
calcium/calmodulin/calcineurin-regulated nuclear factor of activated T-cells (NFAT) 
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pathway. An increase in NFAT translocation has been observed both in dogs and in 
humans with AF, according to a reduction of miR-26 (Luo et al., 2013). 
Experimental evidence has shown an up-regulation of miR-328 in AF patients and has 
identified CACNA1C and CACNB1 genes (which encode L-type Ca
2+
 channels 
subunits), as putative targets (Lu et al., 2010). In this perspective, an up-regulation of 
miR-328 may reduce ICaL density and shorten action potential duration (ADP), thus 
predisposing to an elevated risk of arrhythmia (Lu et al., 2010). 
More recently, a strong association between miR-499, that is up-regulated in AF atrial 
tissue samples, and the gene KCNN3, which encodes the small conductance Ca
2+
 
activated K
+
 channel 3 (SK3) has been observed, suggesting a possible contribute to the 
electrical remodeling process (Ling et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C: miRNAs in AF-associated electrical remodeling (Luo et al., 2015). 
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MiRNAs involved in structural remodeling 
 
Structural remodeling represents a key component responsible for atrial structural 
changes occurred during the fibrotic process, that can be directly related to the onset of 
AF. Multiple miRNAs as miR-21, miR-29, miR-30 miR-133, miR-590 and miR-26 
have been indicated as potential participants in the modulation of the fibrotic 
remodeling process during AF (Figure D). 
miR-21, which is highly expressed in cardiac fibroblasts, targets and represses the 
translation of Sprouty-1 (SPRY1), which represents a negative regulator of the 
extracellular signal-regulated kinase ERK (a member of the mitogen-activated protein 
kinase family) pathway (Thum et al., 2008). ERK activation promotes fibrosis, so its 
derepression via miR-21, which induces the downregulation of SPRY1, results pro-
fibrotic. Experimental studies on animal models have shown that cardiac disfunction 
consequently to myocardial infarction, results in an enhanced susceptibility to AF (as a 
consequence of atrial fibrosis) and miR-21 up-regulation (Cardin et al., 2012). The up-
regulation of miR-21 was consistent with SPRY1 downregulation, and also with an 
increase in ERK phosphorylation. In addition, other studies demonstrated that miR-21 
knockdown suppressed atrial fibrosis, preventing AF development in rats with 
myocardial infarction (Cardin et al., 2012). It has also been observed that AF patients 
have increased levels of miR-21, as a result of the activation of the p21-
Rac1/connective tissue factor (CTGF)/lysyl oxidase pathway (Adam et al., 2012). 
 
miR-29 has been recently suggested as a mechanistic contributor in AF, by regulating of 
numerous extracellular matrix genes, such as collagen, elastin and fibrillin. Experimental 
studies revealed a down-regulation of miR-29 in dogs with heart failure, as well as an 
increase in extracellular matrix proteins, predisposing to AF (Dawson et al., 2013). In 
addition, some in vivo miR-29 knock-down studies have indicated an increase in collagen 
production, while a decrease in miR-29b expression has been observed in both atrial and 
blood samples from patient with AF (Dawson et al., 2013). 
Downregulation of miR-30 and miR-133 has been indicated to contribute to ventricular 
fibrosis during cardiac hypertrophy via CTGF derepression (Duisters et al., 2009). 
Accordingly, an increase of miR-30 and miR-133 levels have been demonstrated to 
inversely correlate with CTGF expression in dogs with fibrosis and AF (Li et al., 2012). 
 
Some studies performed on canine models have revealed that the administration of 
nicotine, results in atrial fibrosis promoting AF (Shan et al., 2009). In particular, TGF-
β1 and TGF-β receptor type-2 (TGFR-2) resulted upregulated in dogs treated with 
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nicotine, whereas the expression of miR-133 and miR-590 (which target TGF-β1 and 
TGFR-2) was reduced (Shan et al., 2009). Although the causal link has not been 
proven, the downregulation of miR-133 and miR-590 might be responsible for 
fibrogenesis in these animal models. This evidence suggests this mechanism a potential 
factor in the association between AF occurrence and cigarette smoking in humans 
(Andrade et al., 2014).  
miR-26, in addition to its role in electrical remodeling, might also contribute to atrial 
fibrotic remodeling by regulating the expression of the transient receptor potential 
channel 3 (TRPC3) (Harada et al., 2012). TRPC3 is a nonselective cation channel that 
mediates Ca
2+
 entry in different cell types. Therefore, changes in its expression promote 
the activation of Ca
2+
-dependent ERK signalling pathways, resulting in fibroblasts 
proliferation and differentiation which may contribute to atrial fibrosis (Harada et al., 
2012). 
miR-208 is a highly conserved miRNA family which includes two members, miR-208a 
and miR-208b, that share similar nucleotide sequences. miR-208a and miR-208b 
(accompanied also with miR-499), are defined as "Myomirs" because they control 
muscle myosin content, myofiber identity, and muscle performance (van Rooij et al., 
2009). MiR-208 has indicated required for cardiomyocyte hypertrophy and fibrosis in 
response to stress and hypothyroidism (Van Roij et al., 2007). Transgenic 
overexpression of miR-208a in the heart has demonstrated sufficient to induce 
hypertrophic growth in mice, as well as a pronounced repression of the miR-208 
regulatory targets, such as thyroid hormone–associated protein 1 (THRAP1) and 
myostatin, which represent negative regulators of muscle growth and hypertrophy 
(Callis et al., 2009). The therapeutic inhibition of miR-208a during hypertension-
induced heart failure in rats have shown to prevents cardiac remodeling, improving 
cardiac function, overall health, and survival (Montgomery et al., 2011). 
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Figure D: miRNAs in AF-associated structural remodeling (Luo et al., 2015). 
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AIM OF THE STUDY 
 
 
A major advancement in the understanding of the pathogenesis of AF is the recognition 
that AF induces both structural and molecular alterations in the atria, which in turn 
promotes the recurrence and maintenance of AF (Nattel & Harada, 2014). A hallmark of 
structural remodeling is represented by atrial fibrosis (Allessie et al., 2002; Li et al., 
1999), a phenomenon in which ECM components, primarily fibrillar collagen, 
accumulate between muscle fibers. The increase in interstital collagen influences both 
the mechanical and the electrical properties of the heart, increasing muscle stiffness and 
reducing coupling between adjacent cardiomyocytes (Weber et al., 2013). A role for 
fibrotic tissue in wave break formation (Wu et al., 1998), conduction delays and “zig-
zag” course of conduction (de Bakker et al., 2006; Kawara et al., 2001), it is also 
exacerbate by the complex 3D structure of the atrium (Rodefeld et al., 1997). In this 
perspective, a better knowledge of the fibrotic content within the myocardial tissue wall 
may provide novel insights of the structural features that characterize a pro-arrhythmic 
substrate. In particular, to date no information about the fibrotic content and the 
intramural distribution throughout the human atrial wall are available.  
The first aim of the present study was to investigate the structural properties of the atrial 
tissue, which may contribute to the formation of a pro-arrhythmic substrate. By using 
both histological and advanced microscopy techniques, the collagen content and its 3D 
properties were determined in atrial tissue samples collected during cardiac surgery, in 
patients who developed or not AF. In particular, for the first time, the 3D intramural 
profile of fibrotic content was determined. In addition to a quantitative assessment, the 
3D properties of collagen fibers as orientation (degree and anisotropy) and scale 
dimension, were evaluated by using non-linear optical microscopy techniques, such as 
two-photon microscopy and SHG.  
In the recent years, a growing body of evidence has suggested that also an altered 
regulation of gene expression may play an important role in the mechanisms of atrial 
remodeling, which underlie AF (Kim et al., 2005; Thijssen et al., 2002). Nonetheless, 
the frequent mismatch between mRNA and protein levels of gene expression has 
promoted the investigation of the regulatory mechanisms, at the post-transcriptional 
level. In particular microRNAs, which are a class of small endogenous non-coding 
RNAs that negatively regulate gene expression, have shown to be involved in the 
control of the mechanisms governing AF, thus providing novel insights into the 
38 
 
molecular basis of the pathogenesis of AF (Luo et al., 2015; Santulli et al., 2014; Wang 
et al., 2011).  
The second aim of the study was to investigate the expression pattern of some miRNAs 
known to target different genes involved in diverse mechanisms that underlie AF and to 
correlate this with histological features, in order to find a possible relationship between 
the expression of miRNAs and the fibrotic content. MiRNAs expression levels were 
analyzed by RT-qPCR analysis of atrial tissue samples, collected from cardiac surgery 
patients in AF or in normal sinus rhythm. To accurately determine the levels of 
analyzed miRNAs, their expression data are usually normalized relatively to 
endogenous and/or exogenous reference genes. To date, no general agreement between 
different normalization strategies has been found. In addition, there is a lack of 
information regarding reliable housekeeping genes for miRNAs analysis in cardiac 
tissue, in particular for the study of AF. For these reasons, a preliminary study aiming to 
establish the best endogenous reference genes for miRNAs data normalization, was 
performed. Different well-established analysis tools were applied on five commonly 
used endogenous reference transcripts. The suitable reference gene thus obtained was 
applied to miRNAs’ data normalization. 
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CHAPTER 2: STRUCTURAL CHARACTERIZATION 
 
The impulse propagation in the heart depends on the excitability of individual 
cardiomyocytes, the impulse transmission between them and their 3-dimensional (3D) 
arrangement. These factors operate across a wide range of spatial scales, and normal 
function at each level ensures that electric activation spreads across the cardiac 
chambers in a stable rhythm, thus triggering efficient contraction (Smaill et al., 2013). 
The normal myocardium consists of two major components, a cellular part and an 
acellular component, which is represented by the extracellular matrix (ECM). The 
cardiac ECM, that is mainly constituted by a network of fibrillar collagen fibers 
(Caulfield & Borg, 1979), represents the three-dimensional scaffold that defines the 
geometry and the muscular architecture of the cardiac chambers. The discontinuous 
arrangement of myocytes and extracellular connective tissue at the tissue scale can give 
rise to current source-to-sink mismatch, spatiotemporal distribution of refractoriness, 
and rate-sensitive electric instability, that contribute to the initiation and maintenance of 
reentrant cardiac arrhythmias (Smaill et al., 2013). During disease progression collagen 
fibers undergo both qualitative and quantitative changes, that can interfere with the 
electrical impulse propagation, thus predisposing to arrhythmogenesis (Tarone et al., 
2014). Knowledge about the content and distribution of fibrosis may be of relevance in 
the context of AF, where the dynamic patterns of wavelet propagation can be supported 
by the 3D collagen structure. 
 
To investigate the tissue properties that can be involved in the formation of a pro-
arrhythmic substrate, a structural characterization of human atrial samples obtained 
from patients undergoing cardiac surgery who developed or not AF, has been 
performed. Particular attention was devoted to fibrosis content, quantified by using the 
well established histological staining method Picrosirius red (Junqueira et al., 1979) in 
combination with a specific image analysis tool. It is well accomplished that interstitial 
fibrosis creates conduction delay causing the electrical impulse to propagate through 
alternative pathways, eventually impinging on tissue that has already recovered 
excitability, thus causing reactivation and a further increase in the number of re-entrant 
circuits (Allessie et al., 2002; Nattel, 2002). More recently, experimental (Eckstein et 
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al., 2011, 2013; Schuessler et al., 1993) and clinical (Allessie et al., 2010; de Groot et 
al., 2010) mapping studies have shown that the dynamic patterns of wavelet 
propagation can be further complicated by the three-dimensional structure of the atria 
and the presence of epi-endocardial dissociation, which can support 3D reentrant 
circuits and epicardial breakthrough. Despite some studies have described the 
histological substrate of atrial fibrillation in humans (Frustaci et al., 1997; Nguyen et 
al.,2009), no information about the 3D collagen content within the human atrial wall 
has been provided. For these reasons, the 3D intramural profile of fibrotic content in the 
atrial wall was investigated here for the first time. Specifically, 5 microns serial tissue 
sections crossing the whole biopsy were collected, imaged and analyzed, in order to 
provide the complete intramural profile of fibrotic content throughout the atrial tissue, 
i.e., from the outer side (the epicardium) to the inner side (the endocardium) of the atrial 
wall. Clinical studies have suggested that in addition to its amount, also the pattern of 
fibrosis may play an important role in arrhythmogenicity (Kawara et al., 2001). In this 
perspective, non-linear optical (NLO) microscopy techniques, such as two-photon 
excited fluorescence (TPEF) and second harmonic generation (SHG) microscopy, have 
been recently indicated as powerful tools for the imaging of thick specimens (Helmchen 
& Denk, 2005; Rubart, 2004). In particular, SHG microscopy thanks to its high 
sensitivity to collagen and intrinsic optical sectioning capability, has been used to reveal 
collagen organization in a variety of tissues, including human dermis, keloid and tumor 
microenvironment (Adur et al.,2014; Cicchi et al., 2010, 2013). Nevertheless, the 
application to human cardiac tissues (Caorsi et al., 2013; Martin et al.,2013), and in 
particular to the relation between atrial collagen and AF, remain sparse (Chiu et al., 
2010; Tsai et al., 2010). In the second part of this chapter, a detailed analysis of 3D 
collagen network properties was performed by applying SHG microscopy to atrial 
tissue samples collected in cardiac surgery patients with or without AF. A quantitative 
assessment of collagen network properties, such as orientation and texture scale along 
tissue depth, was obtained by applying a spectral analysis framework on SHG images. 
The combination of the results derived from these different methodological approaches, 
aiming to define the quantity and the 3D spatial pattern of the collagen network 
throughout the atrial tissue, could provide new important information about the 
structural characterization of AF substrate. 
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2.1 Quantification of collagen content and intramural distribution in 
human atrial tissue samples by Picrosirius red staining 
 
 
MATERIALS AND METHODS 
 
Human tissue collection and processing 
 
Tissue specimens from the right atrial appendage were collected from 15 individuals 
(all males) undergoing cardiac surgery. In particular, seven patients (range 61 ± 12 
years) presented in normal sinus rhythms following intervention (SR group), while eight 
patients (range 74 ± 5 years) displayed AF (AF group). After excision cardiac biopsies 
were immediately fixed in 4% formalin buffered solution and stored at room 
temperature (RT). Subsequently, tissue specimens were dehydrated in graded alcohols, 
embedded in paraffin and cut in 5 µm serial sections (sections per sample ~ 100; stained 
sections ~ 50) by using a microtome (Leica Biosystems, Milan, Italy). Tissue sections 
were collected and stored at RT until staining procedures. 
 
Picrosirius red staining 
 
Tissue sections were placed in an oven at 60°C for one hour and subsequently in two 
stages of xylene (1X for 30 minutes, 1X for 5 minutes) for deparaffinization. After that 
they were hydrated to distilled water by graded alcohols (2X 100%, 1X 90%, 1X 70%, 
5 minutes each). After a pre-treatment with 0,2 % solution of aqueous phosphomolybdic 
acid (Sigma-Aldrich, Milan, Italy) for 2 minutes, the selected tissue sections were 
stained with 0.1% solution of Sirius Red F3BA (Direct Red 80, CI 35780) (Sigma-
Aldrich, Milan, Italy) in saturated aqueous solution of picric acid for one hour, at room 
temperature. Sections were subsequently rinsed in two stages of acidified water, 1 
minute each, and 70% ethanol for 45 seconds. Sections were dehydrated in ascending 
concentrations of ethanol (1X 80%, 1X 90%, 2X 100%, 5 seconds each) and cleared in 
two stages of xylene for 5 seconds each. Slices were finally mounted with a drop of 
mounting medium and a glass cover slip. 
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Imaging and quantification of fibrosis 
 
Picrosirius red stained sections were examined by light microscopy (DMIL microscope 
combined with DFC420 camera, Leica, Germany). Section images were acquired (Leica 
Application Suite, Leica, Germany) randomly within the entire tissue area at 
magnification 4X by using both bright field and polarized light (images per sample 
~100; overall images ~1400). Captured images were subsequently analyzed using a 
custom made software, developed in Matlab R2013b (MathWorks Inc., Natick, 
Massachusetts, US), able to identify and quantify Picrosirius red signals. Specifically, in 
order to quantify collagen content in each sample, both bright field and polarized light 
images were used (Figure 1). All the images were corrected from the vignetting effect 
of the lenses (decrease in brightness at the periphery of the image) by dividing each 
image by a vignetting profile built from a white image acquired at the beginning of each 
microscopy imaging session. 
The corrected bright field images were white-balanced via RGB histogram analysis, 
which also allowed to automatically segment the background region from the tissue 
region. Polarized light images were normalized assuming that picrosirius red signal was 
proportional to collagen density and tissue thickness. The normalized polarized light 
images were thresholded, separating regions with high-density collagen from poor 
density ones. Finally, the fraction of the tissue composed of collagen was computed as 
the ratio of the area of the collagen region over the total tissue area previously 
segmented. The 3D profile of collagen content was obtained in each patient by 
displaying the fraction of collagen in subsequent sample slices as a function of the slice 
depth, going from the epicardial to the endocardial walls. Fibrosis spatial profiles were 
fitted by an exponential decay curve: 
 
, 
 
where y(x) is the fibrosis fraction at depth x and A1, y0 and t1 are positive constants. 
The parameter y0 obtained from the fit was used as an estimate of fibrosis content in the 
deeper (endocardial) layers. Data fitting was performed in Origin Pro 8 (OriginLab 
Corporation, Northampton, Massachusetts). 
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Figure 1: Main steps of the fibrosis quantification assessed by Picrosirius red staining in 
combination with an optimized image analysis software. Stained sections were examined both on 
bright field and polarized light microscopy. Subsequently, the images were processed by a custom made 
image analysis software, providing the collagen percentage for each section. 
 
 
Statistical analysis 
 
Data are expressed as mean ± standard deviation, or median (interquartile range, IQR), 
depending on data normality (Lilliefor test). Differences between steady state fibrosis 
values in the AF group versus SR group were assessed by Wilcoxon-Mann-Whitney 
test. A p value < 0.05 was considered statistically significant. 
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RESULTS 
 
 
Intramural profile of fibrotic content in the whole population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Intramural profile of fibrotic content. Graph and images referred to a representative patient 
in SR. Tissue sections evaluated N=50; total images analyzed N=100. A) 5 µm tissue section from the 
epicardium stained with Picrosirius red and visualized on polarized light; (B) 5 µm tissue section from the 
endocardium stained with Picrosirius red and visualized on polarized light. 
 
It is well accomplished the an accumulation of collagen fibers across the atrial wall 
may support the propagation of multiple excitation wavelets, creating slow conduction 
areas, barriers to wave propagation and/or anchoring points for reentries. In this 
perspective, a better knowledge about the 3D collagen content throughout the atrial 
wall could be of importance in order to characterize possible mechanistic contributors 
to AF. Figure 2 displays a representative example of the intramural profile of fibrotic 
content, performed by applying Picrosirius red on serial tissue sections (5 µm thickness 
each) along the entire atrial wall. In particular, the central graph shown the percentage 
of collagen content from the outer side (the epicardium, left) to the inner myocardial 
region (the endocardium, right) throughout the atria. The trend of the intramural fibrotic 
content along tissue depth followed an exponential decay behaviour: a rapid decrease in 
collagen content was observed within the first 200 µm (from ~80 to 20%), which was 
followed by a further slight decrease (from ~ 20 to 10%) between 200-400 µm. Finally, 
at a depth of around 400-750 µm collagen content values displayed almost constant 
values of around ~10%, indicating the reaching of a steady state condition. 
This trend of collagen content along tissue depth resulted evident in figure 2A and B, 
which show representative images taken in the epicardium and in the endocardium, 
respectively. In particular, in Figure 2A collagen occupied almost the entire tissue area 
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 (~80%), as highlighted by a strong red signal. On the contrary, in figure 2B collagen 
percentage was relatively low (~10%) as indicated by a very fade signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Average and variability of the intramural profile of fibrotic content in the overall 
population. The fibrotic trend of collagen content assessed in the overall population of patients resulted 
in a consistent average curve. To align different thickness of patients’ samples depth is expressed in 
relative units (fraction, %). N=14 (8 AF, 7 SR). 
 
The results concerning the intramural profile of fibrotic content assessed in the overall 
patient population are represented in Figure 3, which displays the average curve 
obtained by aligning and averaging different patients curves. Despite differencies in 
collagen content values, the decreasing trend of fibrotic content previously described 
was consistently observed in the overall population of patients, resulting in a decreasing 
average curve. In the overall population of patients, the collagen content rapidly 
decreased from 58.5 ± 20.2 % to 29.5 ± 15.2 % within ~ 20% of the total tissue depth. 
A further slight decrease to 19.4 ± 13.5 % was observed in the interval 20-40% of tissue 
depth. Finally, for depths larger than half of the tissue thickness, the average collagen 
content oscillated between 10-11%, with a group variability of 6%. The error bar of the 
fibrotic values at each depth fraction point indicated variability among different 
individuals. 
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Comparison of the intramural profile in AF and SR patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Comparisons of intramural profiles of fibrotic content in AF versus SR patients. Collagen 
content decreases from the epicardium to the endocardium in both AF and SR patients. Higher steady 
state values of fibrotic content are observable in AF. To align different thickness of patients’ samples 
depth is expressed in relative units (%). Representative examples. 
 
Following the analysis of the whole population, the intramural profiles of fibrotic 
content were evaluated in AF compared to SR patients (Figure 4). In accordance with 
previous results, the typical decreasing trend of collagen content along tissue depth was 
observed in both AF and SR individuals. However, marked differences were observed 
in the steady state values of fibrosis (within the 30-100% of depth fraction). 
Specifically, the AF patient showed higher fibrotic values (above 20%) compared to the 
control in SR (mean value ~10%), which suggested the penetration of collagen fibers in 
the deepest myocardial layers in presence of AF. 
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Figure 5: Steady-state fibrotic content in AF versus SR patients. The AF group showed higher steady 
state fibrotic values compared to SR group (p=0.08). N=15 (8 AF, 7 SR). 
 
 
To test the existence of differences in the penetration of fibrosis in the endocardial 
layers between AF and SR patients, the steady state fibrotic content was evaluated in 
each patient by fitting of an exponential decay curve (fit adjusted R2 = 0.92 ± 0.06) and 
the values were compared in the AF versus SR groups. The results are summarized in 
Figure 5 and confirmed the behaviour observed in the representative examples. Indeed, 
the AF group showed higher values of fibrotic content (median 10.3, IQR 7.9-13.0 ) 
compared to SR patients (median 6.2, IQR 2.3-10.6; p=0.08). 
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DISCUSSION 
 
Atrial fibrosis is thought to be one of the most important factors in the formation of a 
substrate for AF (Nattel, 2004; Spach & Boineau, 1997). Atrial fibrosis has been 
observed in biopsies from patients with AF (Kostin et al., 2002) and in patients with 
specific risk factors for AF, such as valvular disease (Anné et al., 2005), rheumatic 
heart disease (Luo et al.,2007; Pham & Fenoglio, 1982), dilated and hypertrophic 
cardiomyopathy (Ohtani et al., 1995) and advanced age (Lie & Hammond, 1988). In 
addition, the histological substrate of atrial fibrillation has been investigated in humans 
(Frustaci et al., 1997; Nguyen et al., 2009), but without providing information on its 3D 
arrangement. The increase in interstitial collagen influences both the mechanical and the 
electrical properties of the heart, increasing muscle stiffness and reducing coupling 
between adjacent muscle fiber bundles. Clinical studies have also suggested a role for 
fibrotic tissue in wave break formation (Wu et al., 1998), conduction delays, conduction 
blocks, and “zig-zag” course of conduction (de Bakker et al., 2006; Kawara et al., 
2001). In this perspective, a better knowledge about the fibrotic content within the atrial 
tissue wall may provide novel insights about the structural features of a pro-arrhythmic 
substrate.  
In this section, a histological method for the assessment of fibrotic content in atrial 
tissue samples was introduced. Specifically, Picrosirius red staining (F3BA), which 
represents one of the most used and sensitive methods for the identification of fibrillar 
collagen (Junqueira et al., 1979), was applied to atrial tissue sections in combination 
with a custom made software optimized for quantitative image analysis. Picrosirius red 
is a strong, linear, anionic dye, which comprises six sulfonate groups that can associate 
along cationic collagen fibers, enhancing their natural birefringence under polarized 
light (Junqueira et al., 1979; Montes & Junqueira, 1991). It is well reported that 
Picrosirius red in association with morphometric image analysis, allows for qualitative 
and quantitative characterization of collagen network both in normal and pathological 
tissues (Lattouf et al., 2014). Nonetheless, despite numerous studies have largely 
indicated its use for the assessment of collagen content in cardiac tissue (Dolber & 
Spach, 1987; Hadi et al., 2011; Iles et al., 2015; Whittaker et al.,1994), none of these 
studies provided information about the 3D fibrotic profile throughout the human atrial 
walls.  
Here for the first time, an accurate method for the quantification of the intramural 
collagen in human tissue atrial samples was described. Specifically, 5 µm thickness 
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serial sections throughout the whole biopsy were collected, imaged, and subsequently 
analyzed by using a semi-automated software customized for quantitative analysis of 
histological images. Despite the time-consuming procedure, this approach offers many 
important advantages. Firstly, in contrast to other traditional techniques used for 
collagen quantification (Diez et al., 1995; Medugorac, 1980), this method produces no 
complete tissue disruption. Secondly, Picrosirius red is an anionic dye so, in contrast to 
the application of fluorescent dyes, the reaction with collagen fibers is highly specific 
and quantitative, thus minimizing the risk to obtain uncertainties or false results. 
Thirdly, the application of a semi-automated software optimized for quantitative 
analysis of histological sections images, allowed for the quantitative and reliable 
analysis of hundreds of images in a relatively short time. 
The quantitative analysis of the intramural profile of fibrotic content performed on atrial 
tissue samples in the overall population yielded a consistent average curve of collagen 
content distribution, throughout the myocardial wall. In particular, a strong decrease in 
the fibrotic content from the outer, the epicardium, to the inner region, the endocardium, 
was consistently observed in the overall population, with collagen content reaching a 
steady state in the deep endocardial layers. Despite this globally decreasing trend of 
collagen was observed in both AF and SR patients, marked differences were observed 
in the steady state values of collagen in the two groups. Indeed, collagen stabilized on 
higher values in the AF versus SR groups, indicating a deeper penetration of fibrosis in 
the myocardial tissue associated with the disease. 
Collectively, these findings support the hypothesis that an accumulation of fibrotic 
tissue within the myocardial wall may represent an important mechanistic contributor in 
the pathophysiology of AF. Studies have indicated that structural changes in cardiac 
disorders often affect passive electrical properties, increasing non-uniformity and 
altering anisotropy. This disturbs normal electrical impulse propagation and is, 
consequently, a substrate for arrhythmia (Dhein et al., 2014). In particular, the results of 
our study suggest that the presence of intramural changes in collagen content and the 
penetration of fibrosis in the deepest myocardial layers in AF patients may participate in 
the formation of a 3D structural substrate, which may favour the maintenance of the 
arrhythmia by supporting intramural reentrant pathways and increased epi-endocardial 
dissociation (Allessie et al., 2010; de Groot et al., 2010; Eckstein et al., 2011, 2013; 
Schuessler et al., 1993). 
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To conclude, the application of an accurate histological approach here described, have 
shown its capability to quantify and detect differences in the collagen content and 
distribution within the atrial tissue wall, in AF versus SR patients. 
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2.2 Quantification of collagen fiber orientation and scale dimension in 
human atrial tissue samples by Non-linear Optical Imaging 
 
 
MATERIALS AND METHODs 
 
Human tissue section collection and preparation 
 
Right atrial appendage samples were collected from 12 individuals (all males) 
undergoing cardiac surgery. In particular, seven patients (range 71±9 years) presented in 
normal sinus rhythm following intervention (SR group), while five patients (range 76±4 
years) displayed AF (AF group). After excision cardiac biopsies were immediately 
fixed in 4% formalin buffered solution and stored at room temperature (RT). Prior to 
the microscope examination, a portion of each appendage (about 10 mm
2
) was separate 
with a scalpel, washed twice in phosphate buffered solution (PBS) and mounted onto a 
custom-made holder, the epicardium facing upward. In order to minimize 
morphological surface variability and preserve sample hydration, a cover slip was 
gently pressed against the epicardial surface by springs. 
 
Nonlinear Optical Imaging 
 
Samples were imaged in a two-photon microscope system (Ultima IV, Prairie 
Technologies, Middleton, WI, USA), combining an upright microscope (BX-61W, 
Olympus, Tokyo, Japan) with a Ti:saffire fs-pulsed laser (Mai Tai Deep See HP, 
Spectra-Physics, Santa Clara, USA) (Figure 6). The system included a pre-chirp module 
for wide-range dispersion compensation. The laser was tuned to 1040 nm for SHG 
imaging. A pockels cell controlled the laser beam power, which was adjusted within 10 
and 20 mW at the sample surface. Galvo-mirrors were used to scan the samples. The 
excitation light was strongly focused onto the sample by a water immersion objective 
(60X, NA 0.9, Olympus) and two fields per patient were acquired The SHG signal was 
collected in an epigeometry, separated from the backscattered excitation light by a 
dichroic beamsplitter (cutoff at 660 nm), and splitted by a PMT dichroic mirror (575 
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nm) into two beams. The first component (channel A) was filtered by a 70 nm bandpass 
filter centred a 525 nm (Chroma Technology, Rockingham, VT, USA), before being 
detected by photomultiplier tubes (Hamamatus Photonics, Hamamatus City, Japan). The 
second component (channel B) was filtered by a bandpass of 607/45nm before 
detection. SHG signal was detected in the channel A. Broadband luminescence of 
elastin was revealed in channel B. 
SHG images were acquired with 512X512 pixel digital resolution, 174 µm field of 
view dimension, using a pixel dwell time of 40 µs. 3D stacks were obtained by optical 
sectioning of the tissue at 1 µm interval from the epicardial surface down to a maximal 
depth of 50 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Two-photon microscopy set-up. Two-photon microscope system (Ultima IV, Prairie 
Technologies, Middleton, WI, USA), was set-up by combining an upright microscope (BX-61W, 
Olympus, Tokyo, Japan) with a Ti:saffire fs-pulsed laser (Mai Tai Deep See HP, Spectra-Physics, Santa 
Clara, USA). 
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Image processing and spectral analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Flowchart of the spectral analysis framework applied to SHG images to extract 
quantitative indexes (cyan boxes) of the scale and orientation properties of the collagen network. 
 
In order to obtain information concerning the 3D properties of the collagen network, 
such as fiber orientation (angle and anisotropy indexes) and scale dimension (dominant 
wavelength index) within the atrial tissue wall, a spectral analysis framework (sketched 
in Figure 7) was applied to the SHG images.   
Image processing and spectral analysis were performed by a custom made program 
developed in Matlab R2013b. The analysis was applied to 738 images (450 SR and 288 
AF) to extract multiple frequency-domain features of the collagen network structure. 
The main steps of the analysis are summarized in Figure 7 and comprised: 1) image pre-
processing to enhance the collagen signal; 2) Fast Fourier Transform (FFT) and noise 
removal; 3) calculation of the radial power density and extraction of the texture scale 
index; 4) computation and diagonalization of the power spectrum covariance matrix and 
extraction of the fiber orientation indexes.  
Image pre-processing was aimed to enhance the collagen signal and reduce the elastin 
component, and consisted in the subtraction of the signal in channel B from the signal in 
channel A. The FFT was calculated on squared ROIs (length L = 174 µm and size N = 
512 pixels) of the pre-processed image I(x,y), applying a 2D Tukey window wT(x,y) (α 
= 0.5, separable form) to reduce spectral leakage at high frequency. A smooth occlusion 
mask, wO(x,y), was applied to exclude non-tissue parts and tissue borders from FFT 
computation. The 2D-FFT, expressed as a function of the spectroscopic wave numbers 
vx and vy, was thus given by: 
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The 2D power spectrum was corrected from both periodic 
and white noise components. Periodic noise was removed by applying a despeckle filter 
in the mid-high frequency region (vx, vy> 10/L) of the PS. White noise was estimated by 
a fitting procedure and subtracted from the PS. 
In order to extract quantitative measures of the scale properties of the collagen texture, 
the radial power density (RPD) was computed as a function of radial wave numbers vi= 
i/L, i=0,1,…N/2, by integrating the power spectrum  = PS-W with respect to the 
polar angle. The integral was estimated as a discrete summation weighted by the ring 
windows rwi: 
 
 
 
 
 
 
Where rwi takes non-zero values only in a 2/L thick zone proximal to vi, according to a 
raised cosine function of the radial wavenumber : 
 
 
 
 
 
 
The scale properties of the collagen network were quantified in terms of the dominant 
wavelength (DW), which was defined based on the percentiles of the RPD distribution. 
The dominant wavelength (DW) was related to the average dimension of the collagen 
texture and was defined as: 
 
 
 
 
where v50 is the 50th percentile of the RPD, restricted to the 0.01-1 m-1 range.  
Two additional indexes, related to the presence of fiber orientation in the collagen 
network, were obtained computing the covariance matrix of  in the [v25 - v75] range. 
The covariance matrix was diagonalized to obtain the eigenvalues, emax and emin, and the 
corresponding orthogonal eigenvectors, vmin and vmax.  
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The dominant orientation of the fibers was indicated by the orientation angle α, defined 
by the direction of vmin in the range 0-180. 
The degree of anisotropy (DA) of the fibers was defined by the two eigenvalues, as: 
 
 
 
 
 
The index ranges between 0 and 1, with 0 indicating the absence of a preferential 
direction (equal eigenvalues in the two orthogonal directions), and values close to 1 
indicating maximal anisotropy (emax dominating over emin). 
 
 
Statistical analysis 
 
Data are expressed as mean and standard deviation or median and interquartile range 
(IQR), as pertinent. The variability of the average direction of the fibers (α) along tissue 
depth in each patient was assessed in terms of standard deviation using circular 
statistics. Statistical differences between index distributions in SR versus AF patient 
images were assessed by Wilcoxon-Mann-Whitney test, given the non-normality of the 
overall distributions (Lilliefor test). A p-value < 0.05 was considered statistically 
significant. 
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RESULTS 
 
Properties of collagen network in AF compared to SR patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Optically sectioned ex-vivo atrial tissue samples from a patient with SR (left panel) and a 
patient with AF (right panel), imaged by SHG microscopy. The White line indicates the Dominant 
Wavelength, DW; the direction of the Red line indicates the dominant orientation of the fibers, while its 
length is proportional to the degree of anisotropy, DA. Representative images. 
 
 
Representative examples of SHG microscopy applied to atrial tissue samples collected 
from SR and AF patients are shown in Figure 8. In the patient with SR (left panel) 
collagen shows a fine architecture characterized by thin fibrils with changing angles and 
directions. Conversely, in the AF patient (right panel) collagen tended to pack-up in 
larger bundles of defined directions. The different properties of the collagen network 
observed in the two samples were quantified by the spectral analysis indexes. As 
concerns the texture scale, the presence of thin fibers in the SR patient resulted in a 
smaller dominant wavelength (DW=10 μm, as indicated by the white line), while fibers 
packing-up in the AF patient led to a higher DW value (DW=17.8 μm). As concerns 
fiber orientation, the structure of thin fibers with varying orientation in the SR patient, 
resulted in a lower degree of anisotropy (DA=0.28, as indicated by the red line) with 
respect to the AF case (DA=0.50), where thick oriented bundles of collagen were 
present. 
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Figure 9: Fiber anisotropy (DA) and scale dimension (DW) in the overall patient population. Degree 
of anisotropy and dominant wavelength values resulted increased in AF compared to SR group. N=12 (5 
AF, 7 SR). *, p<0.001 AF versus SR images. 
 
 
The results of the analysis of the whole image database, summarized in Figure 9, 
confirmed the results of the representative examples, evidencing significant differences 
in the anisotropy and scale properties of the collagen network in the SR versus AF 
patients. In particular, anisotropy values (Figure 9, left panel) resulted higher in AF 
(median 0.30, IQR 0.21-0.44 ) with respect to the SR group (median 0.27, IQR 0.18-
0.38; p<0.001: SR versus AF images). In addition, also dominant wavelength (Figure 9, 
right panel) values resulted significantly increased (median 17.6 µm, IQR 11.3-22.7 
µm) in AF compared to SR patients (median 13.6 µm, IQR 10.5-17.9 µm ; p<0.001:SR 
versus AF images). Nonetheless, high variability was found in the overall results for 
both groups, suggesting possible differences in the properties of collagen throughout 
the tissue. 
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Depth profile in the sub-epicardial layers in AF compared to SR patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Optically sectioned ex-vivo atrial tissue samples from a patient with SR (upper images) 
and a patient with AF (lower images) imaged by SHG microscopy, taken from the epicardium 
(left) and the sub-epicardium (right). Representative images. 
 
 
After the global evaluation of collagen properties in AF compared to SR groups, a 
detailed depth analysis of the 3D collagen network throughout the atrial tissue was 
performed. Figure 10 shows representative SHG images of atrial samples collected from 
SR and AF patients, at different tissue depth. Image analysis of the outer epicardium 
layers (depth of 0-20 µm, Figure 10, left side) and the sub-epicardium (depth of 20-35 
µm, Figure 10, right side), revealed changes in collagen network properties across tissue 
wall. Specifically, in both SR and AF representative patients, collagen scale increased 
passing from the epicardial to the subepicardial layers, as well the main orientation of 
the fibers changed along tissue depth, suggesting fiber rotation. 
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Figure 11: Collagen fibers angles (α)(upper panel) and scale dimension (DW)(lower panel) along 
tissue depth in SR (green) and AF (red) patients. Representative examples. 
 
 
These qualitative considerations were quantitatively confirmed by applying spectral 
analysis to subsequent optical sections throughout the atrial tissue. The results of the in-
depth analysis in two representative AF and SR patients are displayed in Figure 11, 
which shows the change in the average orientation angle of the fibers (α, upper panel) 
and dominant scale of the collagen texture (DW, lower panel) as a function of tissue 
depth. The variation in α values indicates the rotation of collagen fibers rotate along 
tissue depth in both AF and SR patients. Nonetheless, while in the SR patient (in green) 
α showed small oscillations (ranging between 86-122°, standard deviation 10.3°), larger 
oscillations were observed in the AF patient (ranging between 101-167°, standard 
deviation 24.9°), especially within the first 10 μm of depth. As concern scale dimension, 
dominant wavelength values changed along tissue depth in both cases (from 10 to 30 
μm), although larger scale values were observed in the presence of AF (20.2 ± 7.0 μm), 
compared to SR (14.4 ± 7.5 μm). 
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Figure 12: Variability of collagen orientation (α)(A) and scale dimension (DW)(B) in SR (green) 
and AF (red) patient populations at a different depth. N=12 (5 AF, 7 SR); A) *, p<0.05: SR versus 
AF patients; B) *, p<0.001: Epi VS Sub-Epi tissues; ^, p<0.05: SR versus AF images. 
 
 
The results of the analysis of the whole image database, displayed in Figure 12, 
corroborated the results in the representative patients. In terms of orientation changes 
(panel A), the AF group showed larger changes (std) of the fiber direction angle 
throughout the tissue (median 22.5°, IQR 14.1°-25.7°) compared to the SR group 
(median 9.7° , IQR 7.6°-12.1°; (p<0,05: SR versus AF patients). As concerns collagen 
scale (panel B), DW values changed between the epicardium (Epi) and the 
subepicardium (SubEpi), assuming larger values in the epicardial layer in both groups 
(Epi: 11.5 [9.1-14.7] μm ; SubEpi: 17.1 [13.6-21.5] μm in SR; Epi: 14.5 [8.5-17.7] μm; 
SubEpi 22.0 [18.5-25.6] μm in AF). Nonetheless, in both subareas, larger DW values 
were observed in AF as compared to SR patients (p<0.05, AF versus SR images). 
Differently from scale and average orientation, the degree of anisotropy show no 
consistent changes as a function of depth in the overall population. 
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DISCUSSION 
 
 
Experimental and clinical studies have identified in structural remodeling the so-called 
“second factor” in the formation of the AF substrate, and an important contributor for 
arrhythmogenesis (Allessie, 2002; Kottkamp, 2013). Inactive collagenous septa 
between cardiomyocytes may indeed support the propagation of multiple excitation 
wavelets in AF, creating slow conduction areas, barriers to wave propagation and/or 
anchoring points for reentries. For these reasons, an accurate investigation of the 
structural properties of the atrial collagen network is necessary for a mechanistic 
understanding of AF. 
During the last decades, new optical microscopy techniques have been developed that 
use non-linear light-matter interactions to generate signal contrast (Denk et al., 1990; 
Helmchen & Denk, 2002; Mertz, 2004; Campagnola et al., 2003; Zipfel et al., 2003). 
Nonlinear optical microscopy (NLO) techniques, which comprise two-photon excited 
fluorescence (TPEF) and second harmonic generation (SHG) microscopy, possess 
special features that make them less sensitive to scattering and thus suitable for high-
resolution imaging of thick tissue specimens. In particular, SHG microscopy can 
provide morphological and functional images of anisotropic biological structures with 
high hyperpolarizability, such as collagen. Importantly, SHG microscopy represents a 
nondestructive imaging tool that allows a clear and selective visualization of collagen 
fibers, without sample staining or pretreatments (Cicchi et al., 2013). 
In this section, a novel approach for the characterization of collagen network properties 
in atrial tissue samples based on NLO microscopy was described. In particular, by 
applying second harmonic generation (SHG) microscopy in combination with a spectral 
analysis framework, a multiparametric description of the properties of collagen network 
in atrial tissue samples was provided. 
The analysis of SHG images of atrial tissue samples collected from SR and AF patients 
revealed that in SR patients collagen network showed a fine architecture characterized 
by thin fibrils, with changing angles and directions. On the contrary, in AF patients 
collagen tended to pack-up in larger bundles of defined directions. These differences 
were quantified by spectral analysis indexes, which revealed that collagen in AF 
patients displays significantly higher fiber anisotropy and larger scale dimension with 
respect to SR patients. This evidence suggests the remodeling of the atrial connective 
tissue in presence of the arrhythmia, with fibers packing up in larger oriented bundles. 
The optical sectioning capability of NLO microscopy was used to provide a detailed 
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analysis of the 3D collagen features in the epicardial and subepicardial layers (35 μm 
depth). The analysis of the images throughout the outer myocardial layers revealed that 
collagen network properties changed from the epicardium to the sub-epicardium, in 
both AF and SR patients. The results of the whole image database indicated that 
collagen fibers rotated from the epicardium to the sub-epicardial layers in both AF and 
SR groups, assuming larger orientation changes in AF patients. Similarly, collagen scale 
increased from the epicardium to the sub-epicardium, with higher values in AF group. 
Taken together, these findings evidence a spatial rearrangement and thickening of the 
3D collagen network in AF patients, suggesting a possible role in the development of 
the arrhythmia. Accordingly, some studies (Chiu et al., 2010; Tsai et al., 2010) have 
also found larger entropy values of collagen fiber angles in AF versus SR patients, 
although indexes were computed by a different approach. 
The multiparametric description of collagen network revealed that fibers orientation 
(described by angle and anisotropy indexes) and scale dimension (described by 
dominant wavelength values), resulted increased in AF tissues, suggesting possible 
remodeling processes. In this perspective, a growing body of evidence have indicated 
that an increased and disorganized pattern of 3D collagen network across the 
myocardium may impair the electrical impulse propagation, predisposing to the 
formation of epicardial breakthrough as well as 3D reentrant circuits, thus resulting in 
AF. 
The methodology here proposed have also shown its capability to detect and quantify 
differences in the morphology and organization of the collagen network in the atrial 
tissue of AF versus SR patients. These results may provide new information about the 
structural features that characterized a pro-arrhythmic substrate, useful to a better 
understanding of the mechanisms that underlie AF. 
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CHAPTER 3: MOLECULAR CHARACTERIZATION 
 
Over the last decades, different mechanisms have been proposed to explain the 
development and progression of AF. Genetic mutations, functional impairment, 
expression deregulation of ion channels, transporters, intracellular Ca
2+
-handling and 
other relevant proteins, can contribute to creating a structural and metabolic substrate 
which may result in electrical disturbances, predisposing to AF (Wang et al., 2011). In 
this perspective, recent studies have indicated that an altered regulation of gene 
expression may play a pivotal role in the mechanisms of atrial remodeling that underlie 
AF. Nonetheless, the frequent mismatch between mRNA and protein levels of gene 
expression has encouraged many researchers to investigate the regulatory mechanisms 
at post-transcriptional level. In particular, it has been recently demonstrated that 
microRNAs, which are a class of endogenous short RNA sequences that negatively 
regulate gene expression, are involved in the control of AF, thus providing novel 
insights into the molecular basis of the pathogenesis of AF (Luo et al., 2015; Santulli et 
al., 2014; Wang et al., 2011). A growing body of evidence has indicated that miRNAs 
are differently expressed in the failing myocardium, and may play an important role in 
cardiac disease progression by targeting genes that govern diverse function in cardiac 
remodeling, including myocardial fibrosis (Topkara & Mann, 2011). 
Various methodologies have been applied in order to characterize qualitatively and 
quantitatively the expression patterns of miRNAs, associated with pathological versus 
normal conditions (Moreno-Moya et al., 2014). Nonetheless, qPCR remains the gold 
standard method for detection of specific sets of miRNAs (Chen et al., 2005; 
Schmittgen et al., 2008; Yan et al., 2013). To accurately determine the levels of 
analyzed miRNAs, their expression data are usually normalized relatively to 
endogenous and/or exogenous reference genes. Nevertheless, no general agreement 
between different normalization strategies has been found, to date. In addition, there is a 
lack of information regarding reliable housekeeping genes for miRNAs analysis in 
cardiac tissue, in particular for the study of AF. 
In this chapter, the expression patterns of some miRNAs known to target genes 
involved in different mechanisms that underlie AF were investigated. Specifically, 
human atrial tissue samples collected during cardiac surgery from patients with and 
without AF were processed for high-quality RNA extraction and subsequent qPCR 
analysis. A panel of miRNAs (miR-1, miR-133a/b, miR-30c, miR-29a/b, miR-208a/b, 
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miR-328, miR-499, miR-590 and miR-21) was selected after an accurate review of the 
literature.  
The goal of the study was to test the existence of different miRNAs expression patterns 
between AF patients and individuals in normal sinus rhythm, with particular attention to 
miRNAs involved in fibrotic remodeling. The accomplishment of this goal required the 
performance of preliminary analyses in order to 1. devise a specific protocol for high-
quality RNA extraction from cardiac tissue, and 2. identify a proper endogenous 
reference gene for normalization of miRNA expression levels. The issue of RNA 
extraction is addressed in Appendix (p.122), where four different protocols were tested 
on tissue samples from a “model” pig heart and compared in terms of RNA yield and 
quality. The issue of data normalization is addressed in the first part of this chapter. 
This presents a detailed analysis of the performance of five commonly used endogenous 
reference transcripts (5S, U6, SNORD48, SNORD44, miR-16) by using different well-
established analysis tools, such as NormFinder (Andersen et al., 2004), GeNorm 
(Vandesompele et al., 2002), BestKeeper (Pfaffl et al., 2004) and ∆Ct method (Silver et 
al., 2006). The best reference gene obtained from this preliminary analysis was applied 
for the normalization of miRNAs expression levels in the patients’ population, which is 
presented in the second part of this chapter. The analysis of miRNAs expression profiles 
in patients with and without AF is complemented with a correlation analysis of 
miRNAs levels and previously obtained histological data (see Chapter 2.1), in order to 
identify a possible relationship between miRNAs and fibrosis. 
89 
 
3.1 Determination of the most suitable reference gene for miRNAs’ 
data normalization 
 
 
 
MATERIALS AND METHODS 
 
 
Patient samples 
 
Tissue samples from the right atrial appendage were collected from 20 patients (all 
males) undergoing cardiovascular surgery. In particular, eleven patients (range 67 ± 12 
years) displayed normal sinus rhythm following the intervention (SR group), while nine 
patients (range 76 ± 4 years) displayed AF (AF group). 
 
 
Human tissue processing and RNA isolation 
 
Small biopsies (~25-100 mg) of the right atrial appendage were collected immediately 
after the cardiac intervention, flash frozen on pre-chilled liquid isopentane and stored at 
-80°C until RNA isolation. Samples were treated according to an optimized protocol, 
specifically designed to obtain high quality and high yield RNA extraction (see 
Appendix, p.124). Briefly, frozen tissues samples were placed in a sterile 15 ml 
polypropylene tube containing 1,5 ml of pre-cooled Qiazol reagent (Qiagen, Milan, 
Italy) and subsequently homogenize with a polytron (Omni-TH International, 
Kennesaw, USA) on ice, at the half of the speed. 
The total RNA (including miRNAs) was extracted using the miRNeasy mini kit 
(Qiagen, Milan, Italy) according to the manufacturer’s protocol. RNA concentration and 
purity were assessed spectrophotometrically by Nanodrop ND-1000 (Thermo Scientific, 
Wilmington, DE, USA). RNA integrity was evaluated for each sample using Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). RNA aliquots were 
stored at -80°C until use. 
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Selection of candidate reference genes 
 
Candidate reference genes were selected based on a literature survey (Table 1). In 
particular, the transcripts considered have been used as normalizers in different 
miRNAs’ cardiac tissue studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Summary of the literature-based selection of the candidate reference genes. 
 
 
 
Reverse transcription qPCR (RT-qPCR) 
 
The total RNA isolated from each tissue sample was reverse-transcribed using 
miRCURY LNA
TM 
Universal cDNA Synthesis kit II (Exiqon, Vedbaek, Denmark) 
according to the manufacturer’s protocol. qRT-PCR assays based on SYBR Green I 
were performed using miRCURY LNA
TM
 PCR primers set (Exiqon, Vedbaek, 
Denmark) on the following selected RNAs: 5S, U6, SNORD48, SNORD44B, hsa-miR-
16-5p. qPCR reactions were performed using ExiLENT SYBR
®
 Green master mix 
(Exiqon, Vedbaek, Denmark) in a CFX384 Real-Time PCR Detection System (Bio-Rad 
Laboratories, Milan, Italy). The 10 µl PCR reaction contained 4 µl of the diluted cDNA 
template, 5 µl of SYBR
® 
Green master mix and 1 µl of PCR primer mix. The reaction 
protocol was as follows: 95°C for 10 minutes, followed by 40 amplification cycles of 
95°C for 10 seconds and 60°C for 1 minute. Each  patient sample was assessed in 
technical triplicates. The threshold cycle (Ct) was defined as the fractional cycle number 
at which fluorescence exceeded the given threshold. 
Reference Gene RNA type References 
 
   
 
5S Ribosomal RNA Zhang et al., 2012 
 
   
 
miR-16 microRNA 
Nishi et al., 2013 
 
Roy et al., 2009    
 
   
 
SNORD44 Small nucleolar RNA Ferreira et al., 2014 
 
   
 
SNORD48 Small nucleolar RNA Sauer et al., 2014 
 
   
 
  Satoh et al., 2010 
 
  Cooley et al., 2012 
 
  Adam et al., 2012 
 
U6 Small nuclear RNA 
Villar et al., 2013 
 
García et al., 2013    
 
  Song et al., 2014 
 
  Liu et al., 2014 
 
  Dong et al., 2014 
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Data analysis and software-based selection of endogenous reference genes 
 
Data analysis was performed by a custom made software, developed in Matlab R2013b 
(MathWorks Inc., Natick, Massachusetts, US), which allowed preprocessing of raw data 
and evaluation of reference gene performance according to different algorithms. For 
each patient sample and reference gene Ct values were estimated as average of the 
technical triplicates Cts, after removal of the outliers (Ct values that differed more than 
1 from the Ct median). Ct values or relative expression values (i.e. 2
-(Ct-min(Ct))
), where 
min (Ct) indicates the minimum of the Ct value of the reference gene over the 
population), were used as inputs for subsequent analysis.  
In order to consider different aspects in the evaluation of reference gene performance, 
gene expression stability was evaluated according to four reliable, widely-used 
algorithms, such as GeNorm (Vandesompele et al., 2002), BestKeeper (Pfaffl et al., 
2004), ∆Ct method (Silver et al., 2006), NormFinder (Andersen et al., 2004), which are 
briefly described in the following.  
GeNorm (Vandesompele et al., 2002), the first algorithm introduced to evaluate the 
stability of reference genes, is based on the assumption that the expression ratio of two 
reference genes should be constant across samples. Consistently, a “gene stability 
measure” (M-value) is defined as the average pairwise variation of a particular reference 
gene with all other tested candidate reference gene. Based on M-values, a repeated 
process of stepwise exclusion of the worst scoring reference genes is performed till the 
best pair of reference genes is identified.  
BestKeeper (Pfaffl et al., 2004) uses as input raw Ct data and assumes that proper 
reference genes should display low variability and a similar expression pattern. Thus, 
gene ranking is performed by computing the complete descriptive statistics of the 
reference genes to evaluate their variability and executing pair-wise correlation analysis 
of the genes Cts to evaluate pattern similarities.  
The ∆Ct method (Silver et al., 2006) is based on assumptions similar to GeNorm, but “pairs 
of reference genes” are quantitatively compared based on the variability (standard 
deviation) of the differences of their Cts (∆Ct) over the samples. The stability of each gene 
is thus quantified, as the average of the standard deviations obtained by the pair-wise 
comparisons with all other reference genes. 
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NormFinder (Andersen et al., 2004) is based on a solid mathematical model of gene 
expression and statistical framework, which allows to estimate not only the overall 
expression variation of the candidate genes but also the variations between sample 
subgroups of the same set (e.g., AF versus SR samples). Thus, differently from the 
other methods, the algorithm allows to test candidate genes directly on the disease of 
interest. A stability value ρ is obtained for each candidate gene, which combines intra- 
and inter-group variations, and provides a direct measure of the systematic error 
introduced when using the gene for normalization. 
The results of the four analysis were combined to evaluate the global performance of 
the reference genes. The overall ranking of the genes was obtained as the geometric 
mean of the rankings given by each of the analyses. 
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RESULTS 
 
Quantity and integrity 
 
 
Quantity of total RNA varied between different tissue samples. RIN number were 
comprised between 5.2 and 8.6. (Table 2). 
 
 
Sample Concentration (ng/µl) RIN number 
   
Patient 1 512,32 7,2 
   
Patient 2 1.302 7,5 
   
Patient 3 331,1 7 
   
Patient 4 517,2 5,2 
   
Patient 5 246,2 5,3 
   
Patient 6 104,4 6,9 
   
Patient 7 117,3 6,5 
   
Patient 8 130,4 8,5 
   
Patient 9 117,3 8,2 
   
Patient 10 55 8,3 
   
Patient 11 79 8,2 
   
Patient 12 109,6 7,7 
   
Patient 14 131,3 8,2 
   
Patient 16 79,8 8,6 
   
Patient 17 124,7 8,6 
   
Patient 18 267,8 8 
   
Patient 19 76,1 8,4 
   
Patient 20 69,8 8 
   
Patient 22 85,8 8,4 
   
Patient 23 91,4 8,4 
   
Patient 24 108,9 7,7 
   
Patient 25 139,9 7,1 
   
Patient 26 156,2 8 
   
 
Table 2: Total RNA quantity and integrity for each tissue sample examined. 
 
 
Expression stability of the candidate reference genes-determination of the 
most suitable reference genes 
 
The distributions of the Ct values of the five reference genes over the whole sample set 
are shown in Figure 1, while the descriptive statistics of the distributions given by 
BestKeeper are reported in Table 3. Candidate genes displayed different average values 
and variability levels. 5S RNA showed the highest expression level (lowest average Ct 
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value of 18.9), which is consistent with its role of an essential component of the 
ribosomes of all living organisms. The lowest expression level was observed for 
SNORD44B, which displayed an average Ct value of 26.7. As concerns the variability 
over the whole data set, SNORD48 and miR-16 displayed the lowest standard 
deviations, 0.66 and 0.69, respectively. 5S and U6 showed the highest variability (1.21 
and 1.76, respectively), both beyond the limit of acceptance (<1) for consistent 
normalizers, while SNORD44B displayed a variability at the limit of acceptance (~1). 
The ranking of reference genes based on Ct variability (Figure 2) assessed SNORD48 
as the best and U6 as the worst reference genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: qPCR cycle threshold (Ct) values for the five candidate reference genes obtained from 
human atrial tissue samples. Data are median (solid line), interquartile (box) and 5th and 95th ranges 
(whiskers). Patient population N=20 (11 SR, 9 AF). 
 
 
Candidate        
 
Genes U6 miR-16 5S SNORD48 SNORD44B BK BK 
 
      (N=5) (N=3) 
 
         
NS 20 20 20 20 20 20 20 
 
        
 
geo Mean 
[Ct] 25.51 23.35 18.86 25.29 26.72 23.77 25.08 
 
 
 
       
 
ar Mean [Ct] 25.58 23.37 18.94 25.30 26.75 23.79 25.09 
 
        
 
Min [Ct] 22.49 20.75 15.17 23.88 24.34 21.82 23.86 
 
        
 
Max [Ct] 28.46 24.91 21.49 26.78 28.90 25.22 26.78 
 
        
 
Std [± Ct] 1.67 0.69 1.21 0.66 1.01 0.68 0.57 
 
        
 
CV [% Ct] 6.54 2.94 6.38 2.62 3.78 2.86 2.28 
 
        
 
 
Table 3. Descriptive statistics of the five candidate reference genes, based on their Ct values, as 
provided by BestKeeper. NS = number of samples; geo = geometric; ar = arithmetic; Std = standard 
deviation; CV = coefficient of variance; BK = BestKeeper index, calculated over all genes (N=5) and 
with the exception of the two genes with the highest variability (N=3). 
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The analysis of the correlation provided by BestKeeper is reported in Table 4. 
SNORD48, SNORD44B and 5S displayed significant correlation when compared to 
one another and to BestKeeper (BK) index (N=5), while U6 correlated just with 5S and 
BK index (N=5, calculated over all reference genes). Interestingly, miR-16 did not 
correlate with any other gene nor with BK index (N=5). A significant correlation for 
miR16 was observed only with BK index (N=3), which was calculated excluding the 
two reference genes with variability above tolerance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: BestKeeper ranking for reference gene stability, based on Ct variability (standard 
deviation, std). SNORD48 showed the lowest variability (highest stability) across the analyzed samples. 
Patient population N=20 (11 SR, 9 AF). 
 
 
 
Table 4. Repeated pair-wise correlation analysis of candidate reference genes. Genes are pairwise 
correlated one with another and with the BestKeeper (BK) index, calculated on all genes (N=5) and with 
the exception of the two genes with the highest variability (N=3). For each comparison, the Pearson 
coefficient of correlation (r) and its significance (p-value) are reported. 
  
Versus U6 miR-16 5S SNORD48 SNORD44 
miR-16 -0.239 - - - - 
p-value 0.312     
5S 0.613 -0.123 - - - 
p-value 0.004 0.603    
SNORD48 0.145 -0.033 0.536 - - 
p-value 0.543 0.890 0.015   
SNORD44 0.187 -0.045 0.657 0.911 - 
p-value 0.429 0.851 0.002 0.001  
BK (N=5) versus U6 miR-16 5S SNORD48 SNORD44 
Coeff. of corr. (r) 0.681 0.054 0.922 0.687 0.762 
p-value 0.001 0.821 0.001 0.001 0.001 
BK (N=3) versus U6 miR-16 5S SNORD48 SNORD44 
Coeff. of corr. (r) - 0.450 - 0.849 0.859 
p-value - 0.046 - 0.001 0.001 
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The analysis of gene stability performed by GeNorm is reported in Figure 3, which shows 
the procedure of step-wise exclusion of the candidate genes with the highest M-value 
(poorest stability). The analysis indicated U6 as the worst reference gene (its exclusion 
resulted in a decrease of the M-value from 1.64 to 1.39), while miR16 and 5S followed 
with intermediate stability values (1.39 and 1.12, respectively). The stepwise procedure 
terminated identifying SNORD48 and SNORD44 as the most stable pair of candidate 
genes with an M-value of 0.62. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Expression stability plot for reference gene selection by GeNorm analysis. GeNorm 
proceeds by calculation of the gene stability measure (M-value) per gene from the least (left) to the most 
stable (right). SNORD48 and SNORD44B showed the highest expression stability across the 20 
analyzed samples. Patient population N=20 (11 SR, 9 AF). 
 
Similar results were obtained by application of the ∆Ct method, as displayed in Figure 
4. U6 resulted the least stable gene, with the highest average standard deviation of ∆Ct 
for pairwise comparisons (2.01), followed by miR16 (1.83). Intermediate values of the 
average std were observed for 5 S (1.61). The most stable genes were SNORD48 (1.33) 
and SNORD44B (1.41), first and second of the ∆Ct ranking, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: ∆Ct analysis for reference gene selection. Comparison of the average values of the 
variabilities of ∆Ct values calculated for each candidate gene with the remaining genes. SNORD48 
displays the lowest variability and thus the highest stability across the analyzed samples.  
Patient population N=20 (11 SR, 9 AF).
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The results of the variability analysis performed by NormFinder are displayed in Figure 
5. The top panel (A) shows the overall evaluation in terms of stability index ρ, while 
the lower panel (B) evidences the contributions of inter-group (box) and intra-group 
(whiskers) variations to the stability index. The worst overall performance was again 
shown by U6 (ρ=0.63), which displayed large values of both inter-group (-0.45) and 
intra-group variabilities (1.14). Despite their small inter-group variabilities (-0.13 and 
0.08), 5 S and miR16 displayed very high intra-group variabilities (0.58 and 1.19), 
which severely affected their overall performance (ρ=0.40 and 0.46). SNORD44 
displayed intermediate values of intra-group (0.23) and inter-group variability (0.25), 
ranking second with a ρ=0.39. SNORD48 showed the highest overall stability 
(ρ=0.32), with intermediate inter-group variations (0.25), but the smallest intra-group 
variability (0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Expression stability plot for reference gene selection by NormFinder analysis. A) 
Overall stability index (ρ) of each candidate gene. B) Intergroup (color box) and intra-group (error 
bars) contributions to overall stability of each reference gene. SNORD48 displayed the highest stability 
across the analyzed samples. Patient population N=20. 
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Rank Gene Comprehensive BestKeeper GeNorm Delta NormFinder 
     Ct  
1 SNORD48 1 0.66 0.62 1.33 0.32 
2 SNORD44B 1.9 1.01 0.62 1.41 0.39 
3 5S 3.2 1.21 1.12 1.61 0.40 
4 miR16 3.4 0.69 1.39 1.83 0.46 
5 U6 5 1.67 1.64 2.01 0.63 
 
Table 5. Stability of candidate reference genes according to the four evaluation algorithms. 
Gene are ordered based on their overall performance, where the comprehensive ranking was obtained 
as the geometric mean of the rankings obtained by the four techniques. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Overall ranking of the five candidate reference genes. The overall positioning is 
calculated as the geometric mean of the rankings obtained by BestKeeper, GeNorm, ∆Ct and 
NormFinder analysis. SNORD48 displayed the best overall ranking and U6 the worst. 
 
 
A summary of the performance of the reference genes according to the four different 
algorithms is provided in Table 5, while the global evaluation of gene stability is 
shown in Figure 6. The comprehensive ranking (geometric mean of the four 
rankings) of the reference genes assessed SNORD48 as the most stable gene (it 
performed best according to all algorithms), followed by SNORD44, 5S, and miR-
16. U6 was the least stable gene, displaying the worst overall ranking (it performed 
worst according to all algorithms). 
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DISCUSSION 
 
 
Despite numerous studies have indicated several methods to measure miRNAs 
expression levels, qPCR remain the gold standard technique for detection of certain sets 
of miRNAs. qPCR is a very specific, sensitive and relatively inexpensive assay, which 
allows for the detection of very small quantities of miRNAs in different samples. 
Nevertheless, an accurate normalization of non-biological variances has to be applied in 
order to provide reliable and significant results (Bustin et al., 2002; Pfaffl et al., 2001, 
2002). Non-biological variances refer to variations in PCR efficiency, amount of 
starting material by sample-to-sample variation, RNA integrity, RT efficiency and 
cDNA sample loading (Karge et al., 1998; Mannhalter et al., 2000). In order to 
compensate for these internal non-biological differences, the use of appropriate 
endogenous reference genes, that have to be selected based on their empirically proven 
appropriateness in defined experimental conditions, is essential. In this context, it is 
well accomplished that good reference genes should have low SDs of expression levels 
across samples, as well as similar expression patterns when compared. Control genes, 
which are often referred to as “housekeeping genes”, are frequently used to normalize 
miRNAs expression levels between different samples. Although several genes and 
standardization methods have been applied, to date no general consensus about an 
optimal normalization strategy has been achieved. In this section, a reliable and 
empirically derived reference framework for normalization of qPCR data in human 
atrial tissue samples was introduced. Specifically, five candidate transcripts as 5S 
rRNA, U6, SNORD48, SNORD44, and miR-16 were selected based on a literature 
survey, and their performances were quantitatively evaluated by applying multiple 
proven analysis tools, such as BestKeeper, GeNorm, NormFinder and the DeltaCt (∆Ct) 
methods. This multi-technique evaluation of reference genes allowed us to take into 
account different aspects, which contribute to the concept of gene stability. Indeed, as 
observed in this study, although genes may perform better in terms of overall 
variability, they may display poor similarity of expression or inter/intra-group 
variability. Therefore, all these features need to be properly evaluated and scored for a 
solid and reliable choice of the normalizer. The results obtained by the analysis of the 
qPCR cycle threshold (Ct) values/relative expression of the five candidates according to 
the different techniques, showed that the normalizers displayed different expression 
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levels and variability properties in the patient population considered. In particular, in 
contrast with its frequent use as normalizer, U6 showed the highest variability across 
the entire population compared to the other transcripts, and the highest intergroup 
variability, suggesting its unsuitability as reference gene in this context. Despite its low 
overall variability and inter-group variability, miR-16 displayed a high intra-group 
variations and expression patterns dissimilar from the other reference genes (e.g., poor 
correlation and high variability of ∆Ct), which greatly affected its overall performance. 
5S RNA displayed the highest expression levels compared to the other candidates. 
Indeed, it is an integral component of the large ribosomal subunit in all organisms (Gray 
et al.,1999). 5S showed large variability in the expression levels within the entire 
population, although it showed good correlation with three of the other reference genes, 
suggesting a similar pattern of expression. SNORD44B displayed the lowest expression 
levels compared to the other candidates, and intermediate performance in terms of 
variability and similarity of expression with the other genes. Lastly, SNORD48 showed 
the lowest overall variability of expression and intra-group variations, high similarity 
with other gene expression and intermediate inter-group variability. All these features 
contributed to its best scores according to all algorithms. The overall positioning 
calculated as the geometric mean of the rankings obtained by BestKeeper, ∆Ct, 
GeNorm and NormFinder indicated for SNORD48 the overall best ranking while for U6 
the worst. The scoring of the best and worst reference gene was corroborated by the 
complete agreement of the four technique for their positioning.  
Collectively, the results here proposed were in line with the literature. In this context, 
several works have reported U6 as an unsuitable reference gene for miRNAs studies. In 
a recent study performed by Xiang et al. in serum samples from patients with different 
tumors, they found large fluctuations in RNU6 expression and a relatively stable 
expression of miR-16 (Xiang et al., 2014). A study performed by Lamba and 
collaborators in hepatic tissues indicated that both RNU6 and RNU6B were not suitable 
as endogenous controls for the normalization of miRNAs’ data (Lamba et al., 2014). In 
addition, by the analysis of the levels of RNU6B in serum samples of healthy 
volunteers, intensive care unit patients and patients with liver fibrosis, Benz et al. found 
that RNU6B displayed a high variability between the cohorts, suggesting a disease-
specific dysregulation (Benz et al., 2013). Wotschofsky et al. also found that RNU6B 
was not a suitable normalizer in miRNAs’ expression studies on renal cell carcinoma. In 
addition, they also validated other candidates including RNU48, which resulted the 
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most stably expressed (Wotschofsky et al., 2011). In another study, performed by 
Torres and collaborators in tissue samples of endometrioid endometrial carcinoma they 
identified RNU48 among the most stably expressed snRNAs both in malignant and 
normal tissues (Torres et al., 2013). In contrast, Brattelid and coworkers, after the 
evaluation of several normalization candidates, found RNU6B among the most optimal 
candidates in isolated ex vivo rat hearts (Brattelid et al., 2011). 
To conclude, the choice of an endogenous reference gene is a critical step to avoid 
misinterpreted data and to identify real changes in miRNAs’ expression levels. 
Different reference genes, such as small nuclear/nucleolar RNAs, have been commonly 
used in miRNAs’ expression studies. Despite these small RNAs share similar properties 
and great abundance, their expression levels can change under different experimental 
conditions and may be affected by specific diseases. For these reasons, an accurate 
methodology to test the suitability of these genes for the set of samples under analysis 
should always be validated. This preliminary study identified SNORD48 as the best 
single reference gene. Nevertheless, reference gene combinations can be considered in 
future studies as a way to further improve normalization performance (Vandesompele et 
al., 2002), where allowed by experimental conditions. 
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3.2 MiRNAs expression profiles in AF compared to SR patients 
 
MATERIALS AND METHODS 
 
Patient samples 
 
Tissue samples from the right atrial appendage were collected from 23 patients (all 
males) undergoing cardiac surgery. In particular, fourteen patients (range 67 ± 11 years) 
displayed normal sinus rhythm following the intervention (SR group), while nine 
patients (range 76 ± 4 years) displayed AF (AF group). 
 
Human tissue processing and RNA isolation 
 
The procedure is described in chapter 3.1. (p. 89 ). 
 
Selection of AF-related miRNAs 
 
 
miRNA 
 
 
Change 
 
Target/Effect 
 
Reference 
miR-1 
↓ ↑Kir2.1 -> ↑ IK1 
Girmatsion et al, Heart 
Rhythm, 2009 
↑ ↓ Cx43 -> Slowed conduction 
Wang  et al, J Mol Med, 
2008 
miR-133 ↑ 
↓ IKr 
IKs 
Wang et al, Cardiovasc 
Res, 2010 
miR-328 ↑ ↓ L-type Ca
2+
 channels 
Lu et al, Circulation, 
2010 
Zhang et al, Sci China 
Life Sci, 2011 
miR-21 ↑ 
↑ Fibrosis, dysregulation of collagen-1 
and 3 
Cardin et al, CircEP, 
2012 
↑ Connective tissue growth factor 
(CTGF) 
↑ collagen content 
Adam et al, Basic Res 
Cardiol, 2012 
miR-30 and miR-
133 
 
↓ 
↑ Fibrosis and Inflammation 
Li et al, Mol Med 
Report, 2012 
↑ Connective tissue growth factor 
(CTGF) 
Duisters et al, CircRes, 
2009 
miR-29 (family) ↓ ↑ Fibrotic response 
Van Rooij et al, PNAS, 
2008 
miR-133 and 
miR-590 
↓ 
↑ Transforming growth factor (TGF) 
and collagen 
Shan et al, Cardiovasc 
Res, 2009 
miR-208 ↓ THRAP1 -> Hypertrophy and fibrosis 
Van Rooij et al, Science, 
2007 
Callis et al, J Clin Invest 
2009 
miR-499 ↑ 
↓ SK3 -> shortening of atrial potential 
duration (ADP) 
Ling et al, Heart Rhythm 
2013 
 
Table 1: miRNAs involved in AF mechanisms. 
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As indicated in Table 1, AF-related miRNAs were selected based on a literature survey. 
In particular, some miRNAs have been demonstrated to be involved mainly in ionic 
remodeling (miR-1, miR-133, miR-328 and miR-499), while others in structural 
remodeling (miR-21, miR-30, miR-29, miR-208 and miR-590). 
 
Reverse transcription qPCR (RT-qPCR)  
 
The total RNA isolated from each tissue sample was reverse-transcribed using 
miRCURY LNA
TM
 Universal cDNA Synthesis kit II (Exiqon, Vedbaek, Denmark) 
according to the manufacturer’s protocol. 
RT-qPCR assays based on SYBR Green I were performed using miRCURY LNA
TM
 
PCR primers set (Exiqon, Vedbaek, Denmark) on the following selected miRNAs: hsa-
miR-1, hsa-miR-133a, hsa-miR-133b, hsa-miR-21, hsa-miR-29a, hsa-miR-29b, hsa-
miR-30c, hsa-miR-328, hsa-miR-590, hsa-miR-499a, hsa-miR-208a, hsa-miR-208b 
(see Appendix, p.123). qPCR reactions were performed using ExiLENT SYBR
®
 Green 
master mix (Exiqon, Vedbaek, Denmark) in a CFX384 Real-Time PCR Detection 
System (Bio-Rad Laboratories, Milan, Italy). The 10 µl PCR reaction contained 4µl of 
the diluted cDNA template, 5 µl of SYBR
®
 Green master mix and 1 µl of PCR primer 
mix. The reaction protocol was as follows: 95°C for 10 minutes, followed by 40 
amplification cycles of 95°C for 10 seconds and 60°C for 1 minute. 
All RT-qPCR reactions, including the no-template controls, were performed in 
technical triplicates on a 384-well reaction plate (Bio-Rad Laboratories, Milan, Italy). 
The threshold cycle (Ct) was defined as the fractional cycle number at which 
fluorescence exceeded the given threshold. 
 
Histological correlates 
 
In a subgroup of twelve patients, 6 patients in SR (range 62 ± 12 years) and 6 patients in 
AF (range 76 ± 4 years), histological correlates were available for comparison with 
miRNA expression. As described in chapter 2.1, the 3D fibrosis profile was obtained in 
each patient by a section-by-section semiautomatic, quantitative analysis of 5 µm atrial 
tissue slices, stained by Picrosirius red. Patients’ curves were fitted to extract the steady 
state value of fibrosis (y0) in the endocardial layers. This parameter was compared with 
miRNA expression to identify a potential correlation between miRNA and fibrosis. 
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Data analysis and statistical analysis 
 
For each patient and miR, the Ct value was estimated as the average of the technical 
triplicate Cts, after removal of the outliers (Ct values that differed more than 1 from the 
Ct median). Expression levels were quantified in terms of relative normalized units, 
using SNORD48 as reference gene (RG, see paragraph 3.1). 
 
Expression levels were quantified in terms of normalized units, using SNORD48 as 
reference gene (RG, see paragraph 3.1). Specifically, the normalized expression (NE) of 
a specific miR in a patient was given by: 
 
 
 
where CtmiR is the Ct value of the miR in the patient and CtRG is the Ct of the reference 
gene in the patient. In the equation, the maximal efficiency of the reaction (E = 2) was 
assumed. 
 
Expression data in the AF and SR groups are expressed as median and interquartile 
range (IQR), due to the non-normality of most of the distributions (Lilliefor test). 
Accordingly, differences between miRNA expressions in SR versus AF groups were 
assessed Wilcoxon-Mann-Whitney test, if not differently indicated. Correlations 
between variables were tested by Pearson’s correlation or Spearman’s rank correlation 
analysis, as pertinent. Statistical significance was defined by a p-value < 0.05. 
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RESULTS 
 
 
MiRNAs expression profiles in the overall population of patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Comparison of miRNAs expression profiles in AF versus SR patient groups. Two 
miRNAs (208a and 208b) display statistically significant differences between the two populations, while 
one (miR-499) is close to significance (p=0.07). Data are expressed as normalized expressions 
(normalization using SNORD48 as normalizer). N=23 (14 SR, 9 AF). **, p<0.01; * p<0.05 In the box 
and whisker plot, the dark black line indicates the median, the box the interquartile range, and the 
whiskers the 1.5*IQR interval. Red crosses indicate outlier values. 
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miRNA SR group AF group p-value 
     
miR-1 4.91 [3.34-8.45] 6.46 [4.66-8.05] NS (0.43) 
      
miR-133a 12.83 [9.07-22.10] 19.52 [16.11-35.17] NS (0.27) 
     
miR-133b 8.29 [6.40-13.03] 8.82 [7.95-19.65]   NS (0.26)# 
     
miR-21 2.26 [1.52-4.73] 3.46 [2.53-8.94] NS (0.24) 
     
miR-29a 0.85 [0.64-1.08] 1.16 [0.86-1.46] NS (0.20) 
    
miR-29b 1.03 [0.43-1.37] 1.52 [1.00-1.86] NS (0.09) 
     
miR-30c 2.93 [2.04-3.26] 2.37 [2.17-2.84] NS (0.68) 
    
miR-328 0.098 [0.06-0.12] 0.097 [0.08-0.10] NS (0.92) 
     
miR-590 0.012 [0.009-0.014] 0.010 [0.007-0.014] NS (0.59) 
     
miR-499a 0.11 [0.07-0.23] 0.25 [0.15-0.42] NS (0.07) 
     
miR-208a 0.15 [0.05-0.43] 0.60 [0.42-0.83]            0.0099
#
 
     
miR-208b 0.10 [0.04-0.17] 0.24 [0.12-0.45]              0.02
#
 
      
 
Table 2: Comparison of miRNAs expression profiles in AF versus SR patient groups. Data are 
median [IQR]. Data comparison is performed by Wilcoxon-Mann-Whitney test or Student’s t-test 
(marked by #). NS, not significant. 
 
The results concerning the expression levels of the 12 selected miRNAs are 
shown in Figure 1 and summarized in Table 2. MiRNAs were differently 
expressed between AF and SR patients. In particular miR-1, miR-133a, miR-
133b, miR-21, mir-29a, miR-29b, miR-208a, miR-208b and miR-499 resulted 
up-regulated in AF compared to SR group. On the contrary, miR-30c and miR-
590 resulted down-regulated in AF patients compared to SR. Only two miRNAs, 
miR-208a and miR-208b, showed statistical differences between the two groups 
(p<0.01 and p<0.05 for miR-208a and miR-208b, respectively), while only miR-
499 resulted close to a significance (p=0.07). 
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Correlation between steady state fibrosis and miRNAs expression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Correlation between steady state fibrosis and miRNAs expression levels. miR-21 and miR-
208b are the closest to a significant correlation with fibrosis (positive correlation). Red dots indicated AF 
while black dots SR patients. N=12 (6 AF, 6 SR). 
 
 
In order to investigate possible relationships between miRNAs expression levels and 
the fibrotic content (described in chapter 2.1), correlation measurements were 
performed on a sub-group of patients (Figure 2). Mir-1, miR-133a, miR-133b, miR-
30c, miR-29a, miR-29b, miR-208a, miR-328, miR-499, and miR-590 showed no a 
significant correlation with steady state fibrosis. On the contrary, miR-21 (r=0.545; 
p=0.0707) and miR-208b (r=0.49; p=0.11) were the closest to a significant correlation 
with fibrosis. 
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DISCUSSION 
 
In this section, the expression patterns of some miRNAs known to regulate diverse 
genes involved in different mechanisms of AF, such as electrical and structural 
remodeling, were investigated. The aim of the study was to find possible differences in 
miRNAs expression signature between AF patients versus individuals in SR. Human 
atrial tissue samples were collected during cardiac surgery from patients with and 
without AF, processed for RNA extraction, and submitted to qPCR analysis. A panel of 
miRNAs, including miR-1, miR-133a/b, miR-30c, miR-29a/b, miR-208a/b, miR-328, 
miR-499, miR-590 and miR-21, was selected based on a literature survey. Our findings 
revealed that the expression levels of some miRNAs were different in AF compared to 
SR patients. In particular, miR-1, miR-133a, miR-133b, miR-21, mir-29a, miR-29b, 
miR-208a, miR-208b and miR-499, resulted up-regulated in AF compared to SR group. 
Conversely, miR-30c, miR-328 and miR-590 resulted down-regulated in AF compared 
to SR patients. However, among these miRNAs, more marked differences in 
expressions between the two populations were observed for miR-208a and miR-208b, 
followed by miR-499. miR-208 is a highly conserved miRNA family, which includes 
two members, miR-208a and miR-208b, that share similar nucleotide sequences. miR-
208a and miR-208b (accompanied with miR-499), are defined as "Myomirs" because 
they control muscle myosin content, myofiber identity, and muscle performance (van 
Rooij et al., 2009). Myosin (MHC), the major contractile protein of the cardiac muscle, 
is present in two isoforms: α-MHC (fast myosin) and β-MHC (slow myosin), which are 
encoded by Mhy6 and Mhy7 genes, respectively (Weiss & Leinwand, 1996). In the 
adult heart the Mhy6 gene co-expresses miR-208a, while Mhy7 and Mhy7b (the latter a 
more ancient myosin gene) co-express miR-208b and miR-499, respectively. miR-208b 
and miR-499 are functionally redundant, playing an important role in the specification 
of muscle fiber identity by activating slow and repressing fast myofiber gene programs 
(van Rooij et al., 2009). The deletion of miR-208a results in a decrease of β-MHC 
expression in the adult heart, thus providing evidence that miR-208a is involved both in 
the regulation of the expression of slow myosin genes, as well as in their intronic 
miRNAs (Callis et al., 2009; Van Rooij et al., 2009). Previous studies (Van Roij et al., 
2007) have also suggested the involvement of miR-208 in cardiomyocyte hypertrophy 
and fibrosis in response to stress and hypothyroidism. Nonetheless, transgenic 
overexpression of miR-208a in the heart has been demonstrated sufficient to induce 
hypertrophic growth in mice, resulting in a pronounced repression of the thyroid 
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hormone–associated protein 1 (THRAP1) and myostatin, two negative regulators of 
muscle growth and hypertrophy (Callis et al., 2009). Montgomery and collaborators 
performed a study where they evaluated a therapeutic approach based on the 
manipulation of miR-208a levels (Montgomery et al., 2011). In particular, 
hypertension-induced heart failure mice were injected subcutaneously with antimir-
208a. The resultant miR-208 inhibition prevented pathological myosin switch and 
cardiac remodelling, thus improving overall cardiac function and survival. Other studies 
revealed that antagomir-208a could reduce the stretch-induced expression of endoglin 
and collagen type I in cultured cells (Shyu et al., 2013). Interestingly, clinical studies 
showed that myocardial miR-208a resulted upregulated in patients with heart failure 
compared to the controls (Matkovich et al., 2012). Taken together, these results suggest 
the potential use of miR-208a as a therapeutic target for the modulation of cardiac 
function and remodelling during the progression of heart disease. 
A microarray analysis of miRNAs expression performed by Nishi and coworkers 
showed that 98 miRNAs were differently expressed in right atrial samples from AF 
patients compared to the SR group. Nevertheless, the subsequent validation by qRT-
PCR assays revealed that only miR-21 and miR-208b were upregulated in the AF group 
compared to individuals in SR (Nishi et al., 2013). In another microarray-based study 
on atrial samples from patients with valvular heart disease and AF versus patients with 
valvular heart disease alone, miR-21 resulted up-regulated, while miR-133a, miR-133b 
and miR-30c were down-regulated (Cooley et al., 2012). On the contrary, Lu et al. 
observed a significant up-regulation of miR-328 and a down-regulation of miR-499 in 
the right atrium of AF patients compared to SR individuals (Lu et al., 2010). 
To investigate possible relationships between miRNAs expression levels and the 
fibrotic content correlation analysis was performed. Our analysis revealed that the sole 
miR-21 and miR-208b were close to a significant correlation with fibrotic content.  
A similar study revealed a positive correlation between the expression of miR-21 and 
the percentage of fibrosis, while no significant correlation was observed for miR-208b 
expression (Nishi et al., 2013). These discrepancies in the results may arise from 
different experimental settings and/or diverse methods for data normalization (as 
discussed in chapter 3.1). MiR-21 is universally expressed in mammal organs such as 
the spleen, the small intestine, the colon and the heart (Lagos-Quintana et al., 2002). 
Despite many functional studies have attributed to miR-21 an oncogenic activity, its 
role in cardiovascular biology and disease has just recently received attention (Zhang, 
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2008). MiR-21 is mostly expressed in cardiac fibroblasts, where it targets and represses 
the translation of SPRY1, a negative regulator of the extracellular signal-regulated 
kinase ERK pathway (Thum et al., 2008). ERK activation promotes fibrosis, so its 
derepression via miR-21 results pro-fibrotic. Experimental studies on animal models 
have shown that cardiac dysfunction enhanced susceptibility to AF and miR-21 up-
regulation (Cardin et al., 2012). In addition, other studies demonstrated that miR-21 
knockdown suppressed atrial fibrosis, preventing AF development in rats with 
myocardial infarction (Cardin et al., 2012). It has also been observed that AF patients 
may have increased levels of miR-21 as a result of the activation of the p21-
Rac1/CTGF/lysyl oxidase pathway (Adam et al., 2012). 
In conclusion, the present study has revealed differences in miRNAs expression levels 
in AF versus SR patients and the existence of a relationship between the expression of 
some miRNAs and the fibrotic content. These findings could be of importance to 
characterize the pro-arrhythmic substrate of AF, thus representing a starting point for a 
better understanding of the molecular mechanisms causing AF. In future studies, major 
attention should be devoted to the study of miR-208a/b and miR-21, which showed 
more marked differences in the expression levels between SR and AF groups and higher 
correlation levels with fibrotic content. Several studies have also demonstrated that 
some miRNAs, including miR-208 and miR-21, are detectable not only intracellularly 
but also in body fluids such as blood, saliva and urine (Zhu & Fan, 2011). In this 
perspective, it could be interesting to perform a comparison between the expression 
levels of miRNAs enriched in myocardial tissue compared to their expression in the 
intravenous blood. These evaluations could be useful in order to explore the possible 
use of miRNAs as predictive biomarkers of fibrotic remodelling.  
It is well known that the function of a miRNA is defined by the genes it targets and its 
effects on their expression. Nonetheless, a given miRNA can be predicted to target 
several hundred genes and different mRNAs have been predicted to be binding sites for 
1 or multiple miRNAs. In this perspective, target determination by bioinformatic 
approaches followed by in-vitro validation techniques will be helpful to investigate the 
functions of selected miRNAs, such as miR208a/b and miR-21, in cardiac remodeling 
processes. In addition, studies aiming to establish miRNA cell type specificity could be 
also performed by applying in-situ techniques (e.g. in-situ hybridization or in-situ PCR). 
Indeed, these methodologies represent a powerful tool to identify and localize a precise 
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miRNAs directly at the tissue site, thus adding also a "molecular-histological" 
perspective to the characterization of atrial tissue. 
 
 
LIMITATIONS OF THE STUDY 
 
Although the present study has provided important information in the characterization  
of the structural and molecular pro-arrhythmic substrate of AF, some limitations need to 
be pointed out. First, the study population available for the analysis was limited, so 
further studies in an extended population are necessary to confirm and strengthen the 
significance of the overall results. In addition, due to sample availability, different but 
partially overlapping subgroups of patients were analyzed by the diverse analysis 
techniques. Second, due to the surgical procedure, only a small biopsy from the right 
atrial appendage was examined, while other parts of the atria, including the left atrium, 
could not be analyzed. Nevertheless, the present evaluation may be considered in line 
with the majority of the studies in the field. Third, human atrial samples were obtained 
from routine cardiac surgery interventions, thus, no “normal tissues” samples were 
available as control. Additional studies are needed to clarify this issue. Fourth, the 
present work was performed with native human tissues, so molecular insights for the 
cause of miRNA dysregulation were not provided. In addition, the exact targets and 
pathways by which alterations in miRNAs cause AF remain elusive. In this perspective, 
additional information about the biological significance of the changes observed in 
miRNAs expression levels in AF patients could be achieved with the development of 
novel experimental models, in which the levels of one or more miRNAs could be 
precisely manipulated and their effects on different cell components evaluated. 
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GENERAL DISCUSSION AND CONCLUSIONS 
 
 
 
This work introduced a novel multi-technique approach for the study of the substrate of 
AF. The study was developed according to two main lines of investigation, structural 
and molecular, to better characterize the features of a potential pro-arrhythmic substrate 
at different scales. New protocols and data analysis tools were implemented and 
developed to define the 3D fibrotic profile and its spatial pattern, as well as to extract 
high-quality RNA and to quantify miRNAs expression in the human myocardium. The 
collagen content and its spatial properties were investigated by applying both 
histological and advanced microscopy techniques to human atrial tissue samples, 
collected during cardiac surgery in patients who developed or not AF. Despite some 
studies have described the histological substrate of atrial fibrillation in humans, no 
information about the 3D collagen content within the human atrial wall has been 
provided. Nonetheless, it is well known that the electrical impulse propagates in a 3D 
atrial substrate and interstitial fibrosis may create conduction blocks at different levels, 
leading the formation of complex 3D reentrant circuits (Nattel, 2002; Allessie et al., 
2002). In the present work an accurate method for the quantification of the intramural 
distribution of collagen in human atrial tissue samples was introduced for the first time. 
5 µm thickness serial sections throughout the whole biopsy were collected, stained with 
Picrosirius red, imaged and analyzed by using a semi-automated software customized 
for quantitative analysis of histological images. The quantitative analysis of the 
intramural profile of the fibrotic content performed on atrial tissue samples in the 
overall population, yielded a consistent average curve of collagen content distribution 
throughout the myocardial wall, with a decrease in the fibrotic content from the 
epicardial to the endocardial wall. The AF group showed higher fibrotic values at the 
steady-state (i.e., in the mid-endocardium), compared to the SR group. Collectively, 
these findings support the hypothesis that an accumulation of fibrosis within the 
myocardial wall may represent an important structural contributor in the 
pathophysiology of AF. In addition to a quantitative analysis, it is also important to 
assess the features of fibrosis to understand how changes in its properties may interfere 
with the electrical impulse propagation. For these reasons collagen properties, such as 
fibers orientation and scale dimension, were evaluated by applying non-linear optical 
microscopy (NLO) techniques and in particular second harmonic generation (SHG). 
These advanced microscopy techniques posses special features that make them less 
117 
 
sensitive to scattering, and thus suitable for high-resolution imaging of thick tissue 
specimens. In particular, SHG microscopy can provide morphological and functional 
images of anisotropic biological structures with high hyperpolarizability, such as 
collagen. Importantly, SHG microscopy represents a nondestructive imaging tool that 
allows a clear and selective visualization of collagen fibers, without sample staining or 
pre-processing. In this work a novel approach for the characterization of collagen 
network properties in atrial tissue samples based on NLO microscopy, was introduced. 
In particular, by applying SHG microscopy in combination with a spectral analysis 
framework, a multiparametric description of the properties of the collagen network in 
atrial tissue samples was provided. The analysis revealed that in SR patients the 
collagen network showed a fine architecture characterized by thin fibrils with changing 
angles and directions, while in AF patients fibers tended to pack-up in larger bundles of 
defined directions. Overall, AF patients displayed collagen fibers with significantly 
higher anisotropy and larger scale dimension. Fibers orientation and scale dimension 
changed along tissue depth in both SR and AF patients, assuming larger values in AF 
tissues. These results highlight a spatial rearrangement and thickening of the 3D 
collagen network in AF patients, which may play a role in the development of the 
arrhythmia. 
Evidence from numerous studies indicates that also an altered regulation of gene 
expression may play an important role in the mechanisms of atrial remodeling which 
underlie AF. Nonetheless, the frequent mismatch between mRNAs and protein levels of 
gene expression has promoted the investigation of the regulatory mechanisms at post-
transcriptional level. In this context, miRNAs have been demonstrated to negatively 
regulate the gene expression of their targets by affecting mRNA stability or translation, 
resulting in repression of target genes. Changes in miRNA expression profiles, 
associated with both electrical and structural modifications, have been identified in 
numerous AF studies, suggesting the use of miRNAs as potential biomarkers and also 
as possible therapeutic targets for the treatment of AF. In the present work, we 
evaluated the expression pattern of some miRNAs known to target different genes 
involved in the mechanisms that underlie AF, in particular in fibrosis/collagen 
formation. A panel of miRNAs was selected based on the literature and analyzed by 
RT-qPCR in atrial samples from AF patients and SR individuals. In addition, to 
accurately determine the levels of analyzed miRNAs, a preliminary study aiming to 
establish the best endogenous reference genes for data normalization was performed. To 
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date no general agreement between different normalization strategies in miRNAs 
expression analysis has been found, resulting in conflicting data across different studies. 
Researchers usually select their endogenous reference genes for miRNAs expression 
according to the literature. Normalizers are usually small nuclear/nucleolar RNAs, 
which display similar properties and are abundantly expressed. Nevertheless, despite 
these transcripts show constant expression in single assays, their expression levels can 
change under different experimental as well as “physiopathological” conditions. 
Therefore, proposed normalizers should be first established across a subset of samples, 
and the combination of multiple reference genes may be more appropriate than a single 
universal normalizer (Shen et al., 2015).  
Multiple miRNAs have been indicated as potential participants in the modulation of 
fibrotic remodeling during AF. In this study differences in the expression levels of a 
subset of AF-related miRNAs, have been observed in AF compared to SR patients. In 
particular, miR-208a and miR-208b displayed more marked differences in expression 
differences between AF and SR patients. These miRNAs have been recently indicated 
as important players in the progression of cardiovascular disorders, such as fibrosis and 
arrhythmia (Huang et al., 2015). Experimental studies have shown that miR-208 family 
is essential to maintain normal myocardial conduction, and it may be a therapeutic 
target in myocardial hypertrophy, fibrosis, and heart failure as well as a potential 
biomarker for acute myocardial infarction (Huang et al., 2015).  
Correlation analysis between miRNAs expression and histologically-assessed fibrotic 
content (described in chapter 3.2) revealed that miR-208b and miR-21 displayed a 
correlation with fibrosis close to statistical significance. Accordingly, miR-21 
upregulation has been indicated to promote fibroblast survival and growth factor 
secretion, as well as to increase the extent of interstitial fibrosis (Thum et al., 2008). 
Interestingly, a similar study performed by Nishi and collaborators indicated a positive 
relationship between the percentage of fibrosis and miR-21, but no significant 
correlations with miR-208b (Nishi et al., 2013).  
 
Future perspectives 
 
Although the present study has provided important information in the characterization  
of the structural and molecular pro-arrhythmic substrate of AF, further studies in an 
extended population are necessary to confirm and strengthen the significance of the 
overall results. 
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In the future, additional investigations should be performed to characterize collagen 
subtypes, such as collagen type I and type III, which are predominant in the cardiac tissue 
and essential for the structural and functional integrity of the myocardium. Indeed, it has 
been shown that  altered expression ratios of collagen types may impact the elasticity and 
stiffness of the heart (Doering et al., 1988), thus enhancing susceptibility to reentrant 
arrhythmias (Weber et al., 1992). Interestingly, a study performed by Grammer and 
collaborators showed that Col III/I ratio was significantly reduced in patients who 
developed AF after cardiac surgery compared to patient in SR, while mRNA expression 
levels remained unvaried (Grammer et al., 2005). This suggests that atrial collagen 
composition is an important factor for the outcome of heart surgery patients with 
respect to the occurrence of AF. For these reasons, further investigations about collagen 
subtypes both at the mRNA and protein level, could provide new information for a 
deeper characterization of a fibrotic pro-arrhythmic substrate. On the other hand, 
concerning the molecular biology part, future experiments should be aimed at clarifying 
the roles of miR-208a/b and miR-21 in AF cardiac remodeling, first by analyzing 
putative target genes (e.g. THRAP1, myosin and SPRY1). In this perspective, 
bioinformatic approaches followed by in-vitro validation techniques and functional 
assays, may be helpful to investigate the possible functions of these miRNAs in cardiac 
remodeling.  
Numerous studies have indicated the possible use miRNAs as potential biomarkers in 
diverse pathological conditions, such as cardiovascular disease. In this perspective, a 
comparison between the expression levels of miRNAs enriched in the myocardial tissue 
compared to their intravenous expression, maybe of great interest. Additionally, 
investigations aiming to establish miRNAs cell type specificity could be performed by 
applying in-situ techniques. Indeed, these methodologies represent a powerful tool to 
identify and precisely localize miRNAs at the tissue site, thus adding value and a new 
"molecular-histological" perspective to the characterization of the atrial tissue. 
To conclude, this work introduced a multiscale approach for the study of the fibrotic 
substrate of AF. However, the clarification of the relationships between the extent and 
distribution of fibrosis, miRNAs expression and the risk of AF requires further 
investigation. To address these issues, a thorough understanding of the ways in which 
structural, molecular and also cellular remodeling alter 3D impulse propagation could 
be helpful for a better understanding of the mechanisms underlying AF, as well as 
beneficial for improving the clinical management of the arrhythmia. 
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APPENDIX 
 
 
 
Oligonucleotide name Target sequence (5’-3’) 
  
hsa-miR-1 UGGAAUGUAAAGAAGUAUGUAU 
  
hsa-miR-133a-3p UUUGGUCCCCUUCAACCAGCUG 
  
hsa-miR-133b UUUGGUCCCCUUCAACCAGCUA 
  
hsa-miR-21-5p UAGCUUAUCAGACUGAUGUUGA 
  
hsa-miR-29a-3p UAGCACCAUCUGAAAUCGGUUA 
  
hsa-miR-29b-3p UAGCACCAUUUGAAAUCAGUGUU 
  
hsa-miR-30c-5p UGUAAACAUCCUACACUCUCAGC 
  
hsa-miR-328-3p CUGGCCCUCUCUGCCCUUCCGU 
  
hsa-miR-590-5p GAGCUUAUUCAUAAAAGUGCAG 
  
hsa-miR-499a UUAAGACUUGCAGUGAUGUUU 
  
hsa-miR-208a-3p AUAAGACGAGCAAAAAGCUUGU 
  
hsa-miR-208b-3p AUAAGACGAACAAAAGGUUUGU 
  
 
List of oligonucleotide names and target sequences (miRCURY LNA
TM
 PCR primers set). 
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This part is included in the abstract “Comparison of different methods to extract RNA 
from cardiac tissue for miRNA profiling by qRT-PCR” by L. Avogaro, M. Grasso, E. 
D´ Amato, F. Tessarolo, S. Sinelli, M. Masè, A. Graffigna, M. A. Denti, F. Ravelli 
published on EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS; 
42 (1)). Springer-Verlag, 2013, p. 191-191. 
 
 
ABSTRACT 
 
Despite the growing interest in cardiac miRNA expression profiling, having high 
quality and yield in RNA extraction from cardiac tissue is still challenging. Different 
methods of tissue homogenization and total RNA extraction from pig cardiac tissue 
aimed at miRNAs expression profiling were compared. Small biopsies of right atrial 
appendages were obtained from pig hearts and treated according to four different 
protocols: no homogenization (P1) and homogenization by manual (P2) or automatic 
(P3 and P4) methods, followed by Proteinase K digestion (PKD) except in P4. Total 
RNA was extracted using miRNeasy mini kit, assessing RNA yield and quality by 
Nanodrop. cDNA synthesis and qRT-PCR were performed using TaqMan MicroRNA 
Assay. Homogenization was crucial to obtain high yield of pure total RNA. Automatic 
methods displayed higher yield (0.27 μg RNA/mg tissue in P3) than manual (0.06 μg 
RNA/mg tissue in P2), with better performance without PKD step (0.38μg RNA/mg 
tissue in P4). RNA from P4 was suitable for miRNA expression profiling, as 
demonstrated by qRT-PCR on miR-21 and miR-29. These results suggest the efficacy 
of an automatic homogenization to extract RNA suitable for miRNA expression 
profiling. 
 
 
METHODS 
 
Tissue processing 
 
Small biopsies of the right atrial appendage were obtained from a pig heart. Samples 
were immediately frozen on liquid nitrogen and subsequently treated according to 
different protocols (Figure 1). 
 
Synthetic protocols’ description: 
 
Protocol n°1 (P1): samples without any grinding processing were incubated with 
Proteinase K for 20 minutes at 55°C; 
Protocol n°2 (P2): samples were pulverized with a pre-chilled mortar and pestle and 
incubated with Proteinase K for 20 minutes at 55°C; 
Protocol n°3 (P3): samples were homogenized at half speed with a rotor stator system 
(Omni TH, Omni International) in a tube containing 1 ml of QIAzol reagent (Qiagen) 
on ice. Samples were incubated with Proteinase K at RT for 10 minutes and 
subsequently centrifuged at 10,000x g for 3 minutes at RT. Finally 100% ethanol was 
added to clear the lysate; 
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Protocol n°4 (P4): samples were homogenized at half speed with a rotor stator system 
(Omni TH, Omni International) in a tube containing 1 ml of QIAzol reagent (Qiagen) on 
ice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Summary of the protocols used for tissue RNA extraction. 
 
 
 
Total RNA was extracted using miRNeasy mini kit, assessing RNA yield and quality by 
Nanodrop. cDNA synthesis and qRT-PCR were performed using TaqMan MicroRNA 
Assay (Applied Biosystems, Life Technologies). 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Total RNA concentration, A260:A280 and A260:230 ratios determined by the Nanodrop. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tissue weight 
(mg) 
Concentration (ng/μl) A260:280 A260:230 
Protocol 1 46,6 20,12 1,55 -0,05 
Protocol 2 50,6 111,2 1,96 0,89 
Protocol 3 45 404,8 2,11 1,24 
Protocol 4 65 822,4 2,08 1,74 
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Figure 2: Total RNA yield for every protocol tested express as μg RNA/mg of tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: qRT-PCR on miR-21 and miR-29a on samples relative at each protocols tested. 
 
 
CONCLUSION 
 
Cardiac tissue homogenization with an automated method without any enzimatic 
digestion allows to obtain good yield and high quality RNA, which is suitable for 
miRNAs profiling. Preliminary results suggests the protocol suitable for applications in 
human heart tissue samples. 
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